data_2l2f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l2f _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 121.195 0.331 . . . . 0.14 112.599 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.74 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 2.1 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.434 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.23 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.14 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.87 110.966 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.59 110.651 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.59 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 1.07 110.724 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.23 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 1.06 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.23 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.23 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 1.03 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 2.11 111.052 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.22 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 1.07 111.244 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.13 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.91 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.29 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.795 0.331 . . . . 1.11 111.264 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 1.15 110.767 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 1.03 111.025 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 1.21 110.982 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.16 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 2.07 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 2.2 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 1.03 111.124 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 1.37 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 2.08 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.7 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.1 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.13 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.12 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.24 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 2.14 110.788 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.86 111.072 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.25 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.51 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 1.05 111.076 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 1.03 110.925 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.02 111.069 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 1.11 110.929 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 1.06 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.93 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.42 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.67 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.38 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.434 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 1.05 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.28 112.308 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 1.63 111.237 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.819 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 2.09 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 1.04 111.131 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.12 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.03 111.061 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.74 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 2.25 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.92 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.76 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.83 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.97 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.92 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.57 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.929 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.85 110.846 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.69 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.11 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.51 111.513 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 1.02 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.09 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.19 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.17 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.97 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.15 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 1.04 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.889 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.99 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 2.15 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.99 110.871 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.17 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.239 0.355 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 97' ' ' ILE . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.411 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CG ' ' N ' ' A' ' 56' ' ' SER . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 4' ' ' PHE . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.151 0.306 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 4.4 t30 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.447 ' CD2' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 HG12 ' CD2' ' A' ' 17' ' ' HIS . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.442 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.41 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.423 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.413 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.131 0.295 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.433 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.405 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' CD1' HD12 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.456 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.456 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.481 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 121.152 0.306 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.45 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.454 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 121.268 0.371 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.4 p80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 3.4 t30 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 5' ' ' HIS . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 48' ' ' PHE . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.316 0.398 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 72' ' ' ILE . 2.2 p80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.402 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.812 0.339 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 5' ' ' HIS . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.337 0 CA-C-O 121.303 0.39 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.465 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 72' ' ' ILE . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.223 0.346 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.446 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.459 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 121.272 0.373 . . . . 0.0 112.355 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.471 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.451 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.468 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.745 0.307 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 74' ' ' VAL . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 121.236 0.354 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.471 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' CE1' ' A' ' 5' ' ' HIS . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.327 0 CA-C-O 121.326 0.404 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.452 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.414 ' CD1' HD13 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CD2' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 17' ' ' HIS . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.411 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.856 0.36 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.413 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 121.246 0.359 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' CD1' HD13 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.476 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.852 0.358 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 121.267 0.371 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.429 ' CD1' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.449 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.406 ' CD1' HD12 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.4 ' NE2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.427 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 56' ' ' SER . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.46 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.19 0.328 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CE1' HD11 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 5.5 t30 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.42 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.485 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 121.198 0.332 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 4.3 t30 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 ' CD1' HD12 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.318 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 56' ' ' SER . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.411 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.267 0.371 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t30 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.458 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD12 ' CA ' ' A' ' 75' ' ' LEU . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.463 HD12 HG23 ' A' ' 72' ' ' ILE . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CA ' HD12 ' A' ' 64' ' ' LEU . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.431 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.319 0 CA-C-O 121.271 0.373 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.414 ' CD1' HD13 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.782 0.325 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.229 0.349 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.448 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 4.3 t30 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.449 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.872 0.367 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.405 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.43 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.481 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 HD12 ' CE2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.219 0.344 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.461 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' HIS . . . . . 0.456 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.804 0.335 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.425 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.413 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.82 0.343 . . . . 3.86 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -92.51 62.66 2.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.773 . . . . 0.14 112.599 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.74 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 2.1 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.434 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.23 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.14 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.87 110.966 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.59 110.651 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.59 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 1.07 110.724 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.23 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 1.06 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.434 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.443 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.23 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.23 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 1.03 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 2.11 111.052 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.434 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.22 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 1.07 111.244 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.13 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.91 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.29 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -33.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.41 -26.41 2.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.63 112.446 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.93 -28.61 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 2.76 110.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.91 -3.87 6.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.7 112.859 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.29 163.4 12.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 1.26 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.48 157.05 17.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 2.2 110.825 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -135.23 114.51 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 1.11 111.264 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 1.15 110.767 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 1.03 111.025 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 1.21 110.982 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 1.03 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.16 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 2.07 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 2.2 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 1.03 111.124 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 1.37 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 2.08 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.7 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.1 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.13 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.12 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.24 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 2.14 110.788 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.86 111.072 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.25 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.51 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 1.05 111.076 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.55 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 1.03 110.925 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 1.02 111.069 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 1.11 110.929 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 1.06 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.93 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.42 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.67 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.38 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.434 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 1.05 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.28 112.308 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 1.63 111.237 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 1.1 110.819 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 2.09 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 1.04 111.131 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.12 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 1.03 111.061 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.74 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 2.25 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.92 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.76 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.83 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.97 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.92 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.57 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.929 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.407 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.85 110.846 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.69 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.11 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.51 111.513 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 1.02 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.09 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.19 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.17 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.97 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.15 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 1.04 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.889 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.99 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 2.15 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.99 110.871 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.17 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.746 0.307 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -78.79 62.37 3.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.226 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.42 ' CD1' HG23 ' A' ' 97' ' ' ILE . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.458 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -28.62 7.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.24 -28.09 3.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.406 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.85 -26.25 66.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.1 7.22 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.938 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.58 161.31 16.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.91 157.86 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.86 125.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.665 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.411 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.423 ' CG ' ' N ' ' A' ' 56' ' ' SER . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' A' ' 4' ' ' PHE . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.21 61.68 1.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' O ' ' CB ' ' A' ' 8' ' ' SER . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 4.4 t30 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.442 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.447 ' CD2' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 HG12 ' CD2' ' A' ' 17' ' ' HIS . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.442 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -38.33 4.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.8 -23.2 2.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.995 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -27.84 69.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.993 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.78 7.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -122.21 163.89 18.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -104.64 157.89 16.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.979 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.64 119.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.523 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.41 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.423 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.413 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.815 0.341 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -96.06 63.2 1.25 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.668 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.433 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.405 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' CD1' HD12 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.456 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.456 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.443 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -28.06 7.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.09 -28.05 3.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.396 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.0 -29.08 69.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -2.32 6.51 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.873 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.93 163.41 13.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -103.03 157.75 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.22 116.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.332 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.434 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.421 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.425 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.481 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.438 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -93.17 61.83 2.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.45 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -37.32 3.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.79 -24.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.66 -27.1 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.85 1.37 8.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.554 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 164.46 13.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.828 0.347 . . . . 0.0 110.755 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -103.96 154.93 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 t -133.31 133.47 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.524 ' HB2' ' HB2' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.454 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -89.46 61.32 3.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.466 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 72' ' ' ILE . 2.4 p80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.409 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 3.4 t30 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -38.13 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.37 -22.66 2.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.076 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -26.4 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 111.043 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.35 1.8 7.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.585 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.28 163.8 19.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.332 . . . . 0.0 110.669 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.407 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 4.6 m-85 -106.23 157.87 17.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.6 128.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.253 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CD1' HD13 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' CE1' ' A' ' 5' ' ' HIS . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 HD13 ' CD1' ' A' ' 48' ' ' PHE . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.421 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.98 60.92 4.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.417 ' CE1' HD11 ' A' ' 72' ' ' ILE . 2.2 p80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.402 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.69 -29.04 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.84 -28.38 2.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.68 -29.36 70.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.96 -4.81 5.71 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.863 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.11 164.12 12.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -103.38 157.84 16.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -134.0 116.8 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.449 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 5' ' ' HIS . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.4 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 mtm . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.797 0.332 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -77.81 63.61 3.44 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.352 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.465 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -28.4 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.28 -24.72 4.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.426 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.88 -27.57 66.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.49 -3.52 5.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.838 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.13 162.86 14.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.1 154.27 21.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -129.58 129.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.229 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.439 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 HD11 HG21 ' A' ' 72' ' ' ILE . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -91.73 62.13 2.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.599 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.43 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.446 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 34' ' ' THR . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -36.57 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.36 -28.3 1.09 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.273 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -65.95 -30.36 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -6.03 6.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.635 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.38 166.12 11.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -105.51 155.95 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.974 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -134.82 114.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.459 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.789 0.328 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -90.37 61.14 3.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.451 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.468 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.468 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.08 -29.26 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.12 -25.25 4.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.12 -28.19 66.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.83 -5.6 5.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.867 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 156.23 18.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.367 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -102.83 153.17 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.16 129.6 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB1' ' A' ' 77' ' ' ALA . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 74' ' ' VAL . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.45 60.89 3.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.682 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.429 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.55 -29.46 6.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.43 -25.63 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.421 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.21 -26.82 68.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.58 -0.33 6.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.99 163.52 15.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -104.4 152.4 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.67 130.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HD13 ' CE1' ' A' ' 5' ' ' HIS . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' GLU . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 92' ' ' ASN . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.471 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -79.43 62.2 4.11 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.294 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.452 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.411 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' CD1' HD13 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CD2' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 17' ' ' HIS . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.411 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -26.32 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.5 -27.02 4.52 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.38 -28.39 69.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.13 -2.35 5.87 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.891 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -115.53 162.73 16.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.779 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -104.68 155.29 18.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t -129.29 129.05 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.611 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.452 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.413 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ttt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.705 0.288 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.19 56.01 4.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.337 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.453 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' CD1' HD13 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.476 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.31 -29.44 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.61 -28.24 2.67 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.432 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 -30.31 68.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.94 -9.31 4.84 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.785 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.66 161.06 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -104.19 157.87 16.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t -138.61 115.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.394 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.403 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.453 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.438 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mtp . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.55 56.06 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.311 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.429 ' CD1' HG22 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.449 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.406 ' CD1' HD12 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.445 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.477 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.4 ' NE2' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.99 4.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.67 -27.64 1.32 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.243 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.36 -29.97 70.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.96 -4.94 6.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.708 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -102.13 165.53 11.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.98 155.72 19.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.33 114.56 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.406 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.427 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' CG ' ' N ' ' A' ' 56' ' ' SER . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.46 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.418 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.41 62.17 1.75 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.623 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.438 ' CZ ' ' CG2' ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.428 ' CE1' HD11 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.407 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 5.5 t30 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.409 ' CD1' HD12 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.25 -26.81 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.61 12.55 7.91 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.707 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -111.85 -24.76 9.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.59 -6.1 4.51 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.824 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -114.03 162.22 16.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -109.93 157.82 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.61 122.61 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.409 HD12 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.428 HD11 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.485 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.414 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.404 HD11 ' CE2' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.771 0.32 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.29 62.7 3.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.567 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.454 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 4.3 t30 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.42 ' CD1' HD12 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.411 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.457 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 HG12 ' CD2' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -37.18 4.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.54 -24.35 2.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.25 -28.18 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.5 0.69 7.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.593 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.85 163.98 13.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.352 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.409 ' CD2' ' HG3' ' A' ' 22' ' ' GLU . 2.9 m-30 -104.49 157.64 17.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t -136.09 114.56 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.422 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 56' ' ' SER . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.411 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -80.29 62.91 4.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.502 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.456 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.457 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t30 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.458 ' CD2' HG12 ' A' ' 18' ' ' ILE . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' OE2' ' CD2' ' A' ' 30' ' ' TYR . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -37.89 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.57 -22.86 2.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.021 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.65 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.982 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.23 3.33 8.83 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.82 163.72 21.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.672 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CD2' ' OE2' ' A' ' 22' ' ' GLU . 4.6 m-85 -105.65 157.91 17.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.58 115.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.391 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.412 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.431 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD12 ' CA ' ' A' ' 75' ' ' LEU . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.463 HD12 HG23 ' A' ' 72' ' ' ILE . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CA ' HD12 ' A' ' 64' ' ' LEU . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.431 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.44 61.76 4.15 Favored Glycine 0 CA--C 1.509 -0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.56 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' CD1' HD13 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.454 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.4 -26.58 8.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 16.96 5.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -112.43 -22.39 10.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 111.114 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.61 0.12 5.78 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.87 163.46 21.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -108.51 157.57 18.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.47 114.66 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.405 ' CD2' ' HB ' ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.419 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.405 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.442 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mmt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.715 0.293 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.11 61.54 4.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.448 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 4' ' ' PHE . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 4.3 t30 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.428 ' CD1' HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.43 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.449 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.427 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.439 ' HA ' ' ND2' ' A' ' 10' ' ' ASN . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.419 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -28.8 8.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.8 -22.27 6.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.05 -26.56 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.46 -2.25 5.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -117.54 159.89 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.764 0.316 . . . . 0.0 110.764 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.421 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 6.1 m-85 -106.46 157.9 17.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t -133.23 122.06 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.574 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 55' ' ' PHE . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 37' ' ' LEU . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.405 ' N ' ' CG ' ' A' ' 55' ' ' PHE . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.481 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 HD12 ' CE2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.65 62.8 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.456 ' CE1' ' CD1' ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' CD1' HD13 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -37.79 4.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.73 -27.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.05 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.76 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.39 6.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.665 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.52 165.56 10.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.884 0.373 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -106.05 157.82 17.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.004 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.51 121.61 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.397 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD13 ' CD1' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.425 ' CD2' ' CG1' ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.416 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.456 ' CD1' ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.425 ' CG1' ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.413 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 121.195 0.331 . . . . 0.13 112.599 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.23 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 1.1899999999999999 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.587 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.17000000000000001 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.28 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.759 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.20999999999999999 110.966 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.5900000000000001 110.651 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.2400000000000002 110.887 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.20999999999999999 110.724 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.20999999999999999 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.28000000000000003 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.1399999999999999 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93000000000000005 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.20000000000000001 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.19 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.664 ' CD1' HD13 ' A' ' 93' ' ' LEU . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 1.3899999999999999 111.052 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.20999999999999999 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.759 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 111.244 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.1299999999999999 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.23999999999999999 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.28999999999999998 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.795 0.331 . . . . 0.28000000000000003 111.264 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.5800000000000001 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.859 ' HB2' HD23 ' A' ' 104' ' ' LEU . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 110.767 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 20' ' ' HIS . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.23999999999999999 111.025 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 40' ' ' TYR . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.51000000000000001 110.982 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 0.16 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.1599999999999999 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 1.28 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 0.16 111.124 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' ND2' HD22 ' A' ' 79' ' ' LEU . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.1899999999999999 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.87 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.1799999999999999 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.089999999999999997 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.12 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.10000000000000001 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 m120 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.05 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.641 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 1.21 110.788 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.20999999999999999 111.072 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.23000000000000001 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.23 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.22 111.076 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0800000000000001 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.17999999999999999 110.925 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.692 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.20999999999999999 111.069 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 93' ' ' LEU . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.33000000000000002 110.929 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.3799999999999999 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.27000000000000002 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.9299999999999999 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.40000000000000002 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.6699999999999999 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.34999999999999998 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.587 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 0.17999999999999999 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.468 ' CB ' HD21 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.23000000000000001 112.308 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.98999999999999999 111.237 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.81 HD11 HG22 ' A' ' 62' ' ' ILE . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.23000000000000001 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 1.6499999999999999 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.19 111.131 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.1200000000000001 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.16 111.061 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.52000000000000002 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26000000000000001 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 1.6299999999999999 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.9199999999999999 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.64000000000000001 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.8300000000000001 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.54000000000000004 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.29 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.5700000000000001 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.929 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.13 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23000000000000001 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' LEU . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.1399999999999999 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.0800000000000001 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.1100000000000001 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.653 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.39000000000000001 111.513 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.10000000000000001 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.089999999999999997 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.16 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.1699999999999999 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.14999999999999999 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 0.22 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.859 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.23000000000000001 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.16 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 1.23 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 96' ' ' ARG . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.29 110.871 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.1699999999999999 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.239 0.355 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.656 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.7 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.508 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.784 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.7 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 20' ' ' HIS . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.931 HG22 HD11 ' A' ' 75' ' ' LEU . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.677 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.656 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HB2' HD21 ' A' ' 64' ' ' LEU . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.501 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD11 HG22 ' A' ' 62' ' ' ILE . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 59' ' ' ALA . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 33' ' ' SER . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.151 0.306 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.569 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.541 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' HA ' HD12 ' A' ' 37' ' ' LEU . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.663 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.878 ' HB2' HD23 ' A' ' 104' ' ' LEU . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 20' ' ' HIS . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.632 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.778 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 75' ' ' LEU . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 74' ' ' VAL . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.458 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CB ' HD21 ' A' ' 64' ' ' LEU . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 62' ' ' ILE . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' NH2' HG11 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.131 0.295 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.538 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.488 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD12 HD13 ' A' ' 93' ' ' LEU . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m120 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 75' ' ' LEU . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 93' ' ' LEU . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' CB ' HD21 ' A' ' 64' ' ' LEU . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 62' ' ' ILE . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.724 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 81' ' ' PRO . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.55 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 19' ' ' LEU . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 121.152 0.306 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.746 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.487 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' OD1' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 25' ' ' ASN . 11.5 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.734 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 37' ' ' LEU . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m120 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CE2' HD13 ' A' ' 62' ' ' ILE . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.872 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 73' ' ' PRO . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.684 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.872 HD11 HG22 ' A' ' 62' ' ' ILE . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 59' ' ' ALA . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.667 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.806 HD13 HD12 ' A' ' 19' ' ' LEU . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 121.268 0.371 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.555 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 ' C ' ' A' ' 8' ' ' SER . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.73 ' HA ' HD12 ' A' ' 37' ' ' LEU . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.438 HD22 HD22 ' A' ' 79' ' ' LEU . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.426 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 75' ' ' LEU . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.687 ' CD1' HD23 ' A' ' 93' ' ' LEU . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 71' ' ' ASN . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 72' ' ' ILE . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 62' ' ' ILE . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.783 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.501 ' C ' HD13 ' A' ' 107' ' ' LEU . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 96' ' ' ARG . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.316 0.398 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 7.1 p-80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.708 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD12 HD13 ' A' ' 93' ' ' LEU . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.812 0.339 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 37' ' ' LEU . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 62' ' ' ILE . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 73' ' ' PRO . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' CB ' HG21 ' A' ' 74' ' ' VAL . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' HA ' HG23 ' A' ' 66' ' ' ILE . 13.3 m120 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.722 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.754 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.771 HD13 HD12 ' A' ' 19' ' ' LEU . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HD22 ' A' ' 107' ' ' LEU . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.489 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.337 0 CA-C-O 121.303 0.39 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.436 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.648 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.635 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 37' ' ' LEU . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 HD13 ' A' ' 93' ' ' LEU . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.751 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 37' ' ' LEU . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.477 HD22 HD22 ' A' ' 79' ' ' LEU . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.692 ' HE2' HG21 ' A' ' 62' ' ' ILE . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HD11 ' A' ' 62' ' ' ILE . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 73' ' ' PRO . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HB2' HD21 ' A' ' 64' ' ' LEU . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD23 ' HB2' ' A' ' 59' ' ' ALA . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.715 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 19' ' ' LEU . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.223 0.346 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 37' ' ' LEU . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.812 ' HB2' HD23 ' A' ' 104' ' ' LEU . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.468 ' CG ' HD22 ' A' ' 79' ' ' LEU . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD1' HD11 ' A' ' 79' ' ' LEU . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 m120 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 62' ' ' ILE . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.962 HG22 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 73' ' ' PRO . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.633 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HB2' HD21 ' A' ' 64' ' ' LEU . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 72' ' ' ILE . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.962 HD11 HG22 ' A' ' 62' ' ' ILE . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.762 HD12 ' CB ' ' A' ' 89' ' ' ALA . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.762 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 121.272 0.373 . . . . 0.0 112.355 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.596 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.664 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 37' ' ' LEU . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.501 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.933 HD12 HD13 ' A' ' 93' ' ' LEU . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.745 0.307 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 20' ' ' HIS . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.871 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 37' ' ' LEU . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' CG ' HD22 ' A' ' 79' ' ' LEU . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 91' ' ' VAL . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' TRP . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.627 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.596 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' C ' HD11 ' A' ' 64' ' ' LEU . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 62' ' ' ILE . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.933 HD13 HD12 ' A' ' 19' ' ' LEU . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 121.236 0.354 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.625 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 8' ' ' SER . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 37' ' ' LEU . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.501 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 13' ' ' LEU . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.482 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 79' ' ' LEU . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.429 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.603 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.84 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.761 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 73' ' ' PRO . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HA ' HG23 ' A' ' 66' ' ' ILE . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.777 HG22 ' OD1' ' A' ' 92' ' ' ASN . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HB2' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.84 HD11 HG22 ' A' ' 62' ' ' ILE . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.779 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 19' ' ' LEU . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.327 0 CA-C-O 121.326 0.404 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.692 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.717 ' HA ' HD23 ' A' ' 64' ' ' LEU . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.682 HD12 HD13 ' A' ' 93' ' ' LEU . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.856 0.36 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.718 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 20' ' ' HIS . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' CG ' HD22 ' A' ' 79' ' ' LEU . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.4 m120 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HE2' HG21 ' A' ' 62' ' ' ILE . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.967 HG22 HD11 ' A' ' 75' ' ' LEU . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 12' ' ' TRP . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' HD11 ' A' ' 72' ' ' ILE . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.4 m120 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.589 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' C ' HD11 ' A' ' 64' ' ' LEU . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 72' ' ' ILE . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.967 HD11 HG22 ' A' ' 62' ' ' ILE . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.752 HD12 ' CB ' ' A' ' 89' ' ' ALA . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.752 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 19' ' ' LEU . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 121.246 0.359 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 1.6 p30 -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD13 ' A' ' 93' ' ' LEU . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.852 0.358 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.85 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 20' ' ' HIS . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 79' ' ' LEU . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.552 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.894 HG22 HD11 ' A' ' 75' ' ' LEU . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.642 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB2' HD21 ' A' ' 64' ' ' LEU . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.894 HD11 HG22 ' A' ' 62' ' ' ILE . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 89' ' ' ALA . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.792 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.778 HD13 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.642 ' HA ' HD22 ' A' ' 107' ' ' LEU . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.85 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 121.267 0.371 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 1.7 p30 -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.452 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.888 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 20' ' ' HIS . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.843 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB2' HD23 ' A' ' 104' ' ' LEU . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.92 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 37' ' ' LEU . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.878 HG22 HD11 ' A' ' 75' ' ' LEU . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.681 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.577 HD21 ' CB ' ' A' ' 73' ' ' PRO . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.649 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.54 ' HA ' HG23 ' A' ' 66' ' ' ILE . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HG22 ' A' ' 62' ' ' ILE . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.778 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 89' ' ' ALA . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.765 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' HD22 ' A' ' 107' ' ' LEU . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.19 0.328 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 16.9 t-20 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.541 ' O ' HD22 ' A' ' 19' ' ' LEU . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.679 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.765 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.601 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 75' ' ' LEU . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 73' ' ' PRO . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 71' ' ' ASN . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.7 m120 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.593 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HB2' HD21 ' A' ' 64' ' ' LEU . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' C ' HD12 ' A' ' 64' ' ' LEU . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 62' ' ' ILE . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.759 HD12 ' CB ' ' A' ' 89' ' ' ALA . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 46' ' ' GLY . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.759 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.509 HD23 ' CD1' ' A' ' 64' ' ' LEU . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.765 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 121.198 0.332 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.589 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 17.2 t-20 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.473 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.318 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 20' ' ' HIS . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 79' ' ' LEU . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 m120 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HE2' HG21 ' A' ' 62' ' ' ILE . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 p30 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 75' ' ' LEU . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' CD1' HD23 ' A' ' 93' ' ' LEU . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 70' ' ' ASP . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.612 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 62' ' ' ILE . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.821 HD23 ' HB2' ' A' ' 59' ' ' ALA . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.267 0.371 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.545 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.596 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 17.7 t-20 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 8' ' ' SER . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 93' ' ' LEU . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.928 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' CG ' HD22 ' A' ' 79' ' ' LEU . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 79' ' ' LEU . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.99 HG22 HD11 ' A' ' 75' ' ' LEU . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 ' HB2' ' A' ' 73' ' ' PRO . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 66' ' ' ILE . 12.4 m120 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.679 ' HB2' HD21 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 64' ' ' LEU . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 62' ' ' ILE . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 88' ' ' GLU . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 87' ' ' VAL . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 19' ' ' LEU . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 107' ' ' LEU . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.502 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.319 0 CA-C-O 121.271 0.373 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.517 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.621 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.513 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.813 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.782 0.325 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.703 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.452 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 75' ' ' LEU . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 93' ' ' LEU . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HA ' HG23 ' A' ' 66' ' ' ILE . 12.4 m120 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 62' ' ' ILE . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 59' ' ' ALA . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.557 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.649 HD23 HD11 ' A' ' 64' ' ' LEU . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.229 0.349 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.424 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 18.0 t-20 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.635 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.659 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.872 0.367 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.619 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m120 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 62' ' ' ILE . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 75' ' ' LEU . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.54 HG22 ' OD1' ' A' ' 92' ' ' ASN . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 64' ' ' LEU . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' ILE . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.992 HD11 HG22 ' A' ' 62' ' ' ILE . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.7 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.54 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HA ' HD22 ' A' ' 107' ' ' LEU . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.519 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.219 0.344 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' HIS . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.805 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.59 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.688 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.691 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.805 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.804 0.335 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.8 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.545 ' ND2' HD22 ' A' ' 79' ' ' LEU . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HD11 ' A' ' 62' ' ' ILE . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.706 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.924 HG22 HD11 ' A' ' 75' ' ' LEU . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 73' ' ' PRO . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.789 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 62' ' ' ILE . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' ' 59' ' ' ALA . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.703 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 64' ' ' LEU . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.8 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.82 0.343 . . . . 3.27 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -92.51 62.66 2.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.773 . . . . 0.13 112.599 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.23 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 1.1899999999999999 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.17000000000000001 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.1399999999999999 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.28 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.759 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.20999999999999999 110.966 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.5900000000000001 110.651 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.2400000000000002 110.887 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.20999999999999999 110.724 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.20999999999999999 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.28000000000000003 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.1399999999999999 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93000000000000005 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.20000000000000001 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.19 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.664 ' CD1' HD13 ' A' ' 93' ' ' LEU . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 1.3899999999999999 111.052 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.20999999999999999 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.759 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 111.244 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.1299999999999999 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.23999999999999999 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.28999999999999998 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -33.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.41 -26.41 2.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.63 112.446 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.93 -28.61 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 2.7599999999999998 110.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.91 -3.87 6.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.69999999999999996 112.859 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.29 163.4 12.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 1.26 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.48 157.05 17.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 1.3 110.825 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -135.23 114.51 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.28000000000000003 111.264 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.5800000000000001 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.859 ' HB2' HD23 ' A' ' 104' ' ' LEU . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 110.767 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 20' ' ' HIS . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.23999999999999999 111.025 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 40' ' ' TYR . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.51000000000000001 110.982 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 0.16 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.1599999999999999 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 1.1799999999999999 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 1.28 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 0.16 111.124 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' ND2' HD22 ' A' ' 79' ' ' LEU . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.1899999999999999 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.87 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.1799999999999999 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.089999999999999997 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.12 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.10000000000000001 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.7 m120 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.05 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.641 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 1.21 110.788 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.20999999999999999 111.072 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.23000000000000001 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.23 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.22 111.076 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.0800000000000001 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.17999999999999999 110.925 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.692 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.20999999999999999 111.069 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 93' ' ' LEU . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.33000000000000002 110.929 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.3799999999999999 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.27000000000000002 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.9299999999999999 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.40000000000000002 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.6699999999999999 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.8 m120 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.34999999999999998 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.587 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 0.17999999999999999 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.468 ' CB ' HD21 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.23000000000000001 112.308 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.98999999999999999 111.237 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.81 HD11 HG22 ' A' ' 62' ' ' ILE . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.23000000000000001 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 1.6499999999999999 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.19 111.131 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.1200000000000001 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.16 111.061 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.52000000000000002 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26000000000000001 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 1.6299999999999999 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.9199999999999999 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.64000000000000001 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.8300000000000001 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.54000000000000004 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.29 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.5700000000000001 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.929 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.13 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23000000000000001 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' LEU . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.1399999999999999 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.0800000000000001 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.1100000000000001 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.653 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.39000000000000001 111.513 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.10000000000000001 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.089999999999999997 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.16 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.1699999999999999 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.28999999999999998 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.14999999999999999 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 0.22 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.859 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.23000000000000001 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.16 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 1.23 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 96' ' ' ARG . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.29 110.871 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.1699999999999999 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.746 0.307 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -78.79 62.37 3.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.226 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.656 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.7 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.508 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.784 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.7 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -28.62 7.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.24 -28.09 3.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.406 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.85 -26.25 66.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.1 7.22 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.938 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.58 161.31 16.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.91 157.86 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.86 125.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.665 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 20' ' ' HIS . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.931 HG22 HD11 ' A' ' 75' ' ' LEU . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.677 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.656 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HB2' HD21 ' A' ' 64' ' ' LEU . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.501 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD11 HG22 ' A' ' 62' ' ' ILE . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 59' ' ' ALA . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 33' ' ' SER . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.21 61.68 1.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.569 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.541 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' HA ' HD12 ' A' ' 37' ' ' LEU . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.663 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -38.33 4.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.8 -23.2 2.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.995 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -27.84 69.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.993 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.78 7.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -122.21 163.89 18.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 3.9 m-85 -104.64 157.89 16.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.64 119.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.523 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.878 ' HB2' HD23 ' A' ' 104' ' ' LEU . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 20' ' ' HIS . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.7 m120 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.632 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.778 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 75' ' ' LEU . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 74' ' ' VAL . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.458 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CB ' HD21 ' A' ' 64' ' ' LEU . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 62' ' ' ILE . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' NH2' HG11 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.479 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.815 0.341 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -96.06 63.2 1.25 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.668 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.538 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.488 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD12 HD13 ' A' ' 93' ' ' LEU . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -28.06 7.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.09 -28.05 3.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.396 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.0 -29.08 69.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -2.32 6.51 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.873 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.93 163.41 13.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -103.03 157.75 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.22 116.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.332 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m120 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 75' ' ' LEU . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 93' ' ' LEU . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' CB ' HD21 ' A' ' 64' ' ' LEU . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 62' ' ' ILE . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.724 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 81' ' ' PRO . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.55 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 19' ' ' LEU . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -93.17 61.83 2.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.746 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.487 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' OD1' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -115.8 -37.32 3.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.79 -24.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.66 -27.1 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.85 1.37 8.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.554 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 164.46 13.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.828 0.347 . . . . 0.0 110.755 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -103.96 154.93 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 25' ' ' ASN . 11.5 t -133.31 133.47 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.734 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 37' ' ' LEU . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.3 m120 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CE2' HD13 ' A' ' 62' ' ' ILE . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.872 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 73' ' ' PRO . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.684 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.872 HD11 HG22 ' A' ' 62' ' ' ILE . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 59' ' ' ALA . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.667 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.806 HD13 HD12 ' A' ' 19' ' ' LEU . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' HD21 ' A' ' 107' ' ' LEU . 3.3 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -89.46 61.32 3.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.466 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.555 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.641 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 ' C ' ' A' ' 8' ' ' SER . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.73 ' HA ' HD12 ' A' ' 37' ' ' LEU . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -38.13 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.37 -22.66 2.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.076 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -26.4 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 111.043 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.35 1.8 7.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.585 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.28 163.8 19.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.332 . . . . 0.0 110.669 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 4.6 m-85 -106.23 157.87 17.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.6 128.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.253 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.438 HD22 HD22 ' A' ' 79' ' ' LEU . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.426 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 75' ' ' LEU . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.687 ' CD1' HD23 ' A' ' 93' ' ' LEU . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 71' ' ' ASN . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 72' ' ' ILE . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 62' ' ' ILE . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.783 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.501 ' C ' HD13 ' A' ' 107' ' ' LEU . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 96' ' ' ARG . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.98 60.92 4.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.423 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 7.1 p-80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.708 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.451 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD12 HD13 ' A' ' 93' ' ' LEU . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.69 -29.04 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.84 -28.38 2.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.68 -29.36 70.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.96 -4.81 5.71 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.863 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.11 164.12 12.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -103.38 157.84 16.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -134.0 116.8 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 37' ' ' LEU . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.0 m120 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 62' ' ' ILE . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 73' ' ' PRO . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' CB ' HG21 ' A' ' 74' ' ' VAL . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' HA ' HG23 ' A' ' 66' ' ' ILE . 13.3 m120 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.722 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.754 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.771 HD13 HD12 ' A' ' 19' ' ' LEU . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HD22 ' A' ' 107' ' ' LEU . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.489 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' HD21 ' A' ' 107' ' ' LEU . 7.9 mtm . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.797 0.332 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -77.81 63.61 3.44 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.352 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.648 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.635 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.505 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 37' ' ' LEU . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 HD13 ' A' ' 93' ' ' LEU . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -28.4 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.28 -24.72 4.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.426 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.88 -27.57 66.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.49 -3.52 5.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.838 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.13 162.86 14.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.1 154.27 21.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -129.58 129.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.229 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.751 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 37' ' ' LEU . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.477 HD22 HD22 ' A' ' 79' ' ' LEU . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.692 ' HE2' HG21 ' A' ' 62' ' ' ILE . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HD11 ' A' ' 62' ' ' ILE . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 73' ' ' PRO . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HB2' HD21 ' A' ' 64' ' ' LEU . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD23 ' HB2' ' A' ' 59' ' ' ALA . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.715 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 19' ' ' LEU . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -91.73 62.13 2.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.599 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 37' ' ' LEU . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -36.57 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.36 -28.3 1.09 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.273 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -65.95 -30.36 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -6.03 6.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.635 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.38 166.12 11.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -105.51 155.95 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.974 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -134.82 114.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.812 ' HB2' HD23 ' A' ' 104' ' ' LEU . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.468 ' CG ' HD22 ' A' ' 79' ' ' LEU . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD1' HD11 ' A' ' 79' ' ' LEU . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.8 m120 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 62' ' ' ILE . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.962 HG22 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 73' ' ' PRO . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.633 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HB2' HD21 ' A' ' 64' ' ' LEU . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 72' ' ' ILE . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.962 HD11 HG22 ' A' ' 62' ' ' ILE . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.762 HD12 ' CB ' ' A' ' 89' ' ' ALA . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.762 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.789 0.328 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -90.37 61.14 3.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.596 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.664 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 37' ' ' LEU . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.501 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.933 HD12 HD13 ' A' ' 93' ' ' LEU . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.08 -29.26 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.12 -25.25 4.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.12 -28.19 66.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.83 -5.6 5.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.867 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 156.23 18.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.367 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -102.83 153.17 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.16 129.6 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 20' ' ' HIS . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.871 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 37' ' ' LEU . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' CG ' HD22 ' A' ' 79' ' ' LEU . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 91' ' ' VAL . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' TRP . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.627 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.596 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' C ' HD11 ' A' ' 64' ' ' LEU . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 62' ' ' ILE . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.933 HD13 HD12 ' A' ' 19' ' ' LEU . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.45 60.89 3.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.682 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.625 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 8' ' ' SER . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 37' ' ' LEU . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.501 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 13' ' ' LEU . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.482 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.55 -29.46 6.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.43 -25.63 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.421 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.21 -26.82 68.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.58 -0.33 6.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.99 163.52 15.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -104.4 152.4 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.67 130.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 79' ' ' LEU . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.429 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.603 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.84 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.761 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 73' ' ' PRO . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HA ' HG23 ' A' ' 66' ' ' ILE . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.777 HG22 ' OD1' ' A' ' 92' ' ' ASN . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HB2' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.84 HD11 HG22 ' A' ' 62' ' ' ILE . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.779 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 19' ' ' LEU . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.441 ' H3 ' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -79.43 62.2 4.11 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.294 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.692 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.717 ' HA ' HD23 ' A' ' 64' ' ' LEU . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.682 HD12 HD13 ' A' ' 93' ' ' LEU . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -26.32 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.5 -27.02 4.52 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.38 -28.39 69.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.13 -2.35 5.87 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.891 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -115.53 162.73 16.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.779 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 3.1 m-85 -104.68 155.29 18.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t -129.29 129.05 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.611 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.718 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 20' ' ' HIS . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' CG ' HD22 ' A' ' 79' ' ' LEU . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.4 m120 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HE2' HG21 ' A' ' 62' ' ' ILE . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.967 HG22 HD11 ' A' ' 75' ' ' LEU . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 12' ' ' TRP . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' HD11 ' A' ' 72' ' ' ILE . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.4 m120 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.589 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' C ' HD11 ' A' ' 64' ' ' LEU . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 72' ' ' ILE . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.967 HD11 HG22 ' A' ' 62' ' ' ILE . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.752 HD12 ' CB ' ' A' ' 89' ' ' ALA . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.752 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 19' ' ' LEU . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD21 ' H3 ' ' A' ' 1' ' ' MET . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.556 ' N ' HD21 ' A' ' 107' ' ' LEU . 2.1 ttt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.705 0.288 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.19 56.01 4.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.337 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 1.6 p30 -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD13 ' A' ' 93' ' ' LEU . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.31 -29.44 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.61 -28.24 2.67 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.432 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 -30.31 68.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.94 -9.31 4.84 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.785 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.66 161.06 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -104.19 157.87 16.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t -138.61 115.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.394 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.85 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 20' ' ' HIS . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 79' ' ' LEU . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.552 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.894 HG22 HD11 ' A' ' 75' ' ' LEU . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.642 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB2' HD21 ' A' ' 64' ' ' LEU . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.894 HD11 HG22 ' A' ' 62' ' ' ILE . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 89' ' ' ALA . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.792 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.778 HD13 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.642 ' HA ' HD22 ' A' ' 107' ' ' LEU . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.85 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.503 ' N ' HD21 ' A' ' 107' ' ' LEU . 22.0 mtp . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.55 56.06 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.311 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 1.7 p30 -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.452 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.888 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 20' ' ' HIS . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.843 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.99 4.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.67 -27.64 1.32 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.243 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.36 -29.97 70.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.96 -4.94 6.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.708 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -102.13 165.53 11.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.98 155.72 19.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.33 114.56 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB2' HD23 ' A' ' 104' ' ' LEU . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.92 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 37' ' ' LEU . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.878 HG22 HD11 ' A' ' 75' ' ' LEU . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.681 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.577 HD21 ' CB ' ' A' ' 73' ' ' PRO . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.649 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' HA ' HG23 ' A' ' 66' ' ' ILE . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HG22 ' A' ' 62' ' ' ILE . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.778 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 89' ' ' ALA . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.765 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' HD22 ' A' ' 107' ' ' LEU . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.41 62.17 1.75 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.623 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 16.9 t-20 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.541 ' O ' HD22 ' A' ' 19' ' ' LEU . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.679 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.25 -26.81 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.61 12.55 7.91 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.707 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -111.85 -24.76 9.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.59 -6.1 4.51 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.824 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -114.03 162.22 16.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -109.93 157.82 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.61 122.61 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.765 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.601 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 75' ' ' LEU . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 73' ' ' PRO . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 71' ' ' ASN . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 66' ' ' ILE . 11.7 m120 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.593 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HB2' HD21 ' A' ' 64' ' ' LEU . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' C ' HD12 ' A' ' 64' ' ' LEU . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 62' ' ' ILE . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.759 HD12 ' CB ' ' A' ' 89' ' ' ALA . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 46' ' ' GLY . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.759 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.509 HD23 ' CD1' ' A' ' 64' ' ' LEU . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.765 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.771 0.32 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.29 62.7 3.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.567 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.589 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 17.2 t-20 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.633 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.473 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -37.18 4.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.54 -24.35 2.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.25 -28.18 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.5 0.69 7.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.593 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.85 163.98 13.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.352 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CD2' ' HG3' ' A' ' 22' ' ' GLU . 2.9 m-30 -104.49 157.64 17.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t -136.09 114.56 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 20' ' ' HIS . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 79' ' ' LEU . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.0 m120 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HE2' HG21 ' A' ' 62' ' ' ILE . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.8 p30 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 75' ' ' LEU . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' CD1' HD23 ' A' ' 93' ' ' LEU . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 70' ' ' ASP . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.612 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 62' ' ' ILE . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.821 HD23 ' HB2' ' A' ' 59' ' ' ALA . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -80.29 62.91 4.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.502 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.545 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.596 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 17.7 t-20 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 8' ' ' SER . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 93' ' ' LEU . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -37.89 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.57 -22.86 2.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.021 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.65 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.982 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.23 3.33 8.83 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.82 163.72 21.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.672 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CD2' ' OE2' ' A' ' 22' ' ' GLU . 4.6 m-85 -105.65 157.91 17.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.58 115.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.391 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.928 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' CG ' HD22 ' A' ' 79' ' ' LEU . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 79' ' ' LEU . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.99 HG22 HD11 ' A' ' 75' ' ' LEU . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 ' HB2' ' A' ' 73' ' ' PRO . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 66' ' ' ILE . 12.4 m120 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.679 ' HB2' HD21 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 64' ' ' LEU . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 62' ' ' ILE . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 88' ' ' GLU . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 87' ' ' VAL . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 19' ' ' LEU . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 107' ' ' LEU . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.502 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.44 61.76 4.15 Favored Glycine 0 CA--C 1.509 -0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.56 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.517 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.621 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.492 ' ND2' ' CD2' ' A' ' 30' ' ' TYR . 8.0 p30 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.513 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.813 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HB2' ' ND2' ' A' ' 9' ' ' ASN . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.4 -26.58 8.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 16.96 5.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -112.43 -22.39 10.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 111.114 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.61 0.12 5.78 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.87 163.46 21.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.492 ' CD2' ' ND2' ' A' ' 9' ' ' ASN . 3.6 m-85 -108.51 157.57 18.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.47 114.66 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.703 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 75' ' ' LEU . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 93' ' ' LEU . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HA ' HG23 ' A' ' 66' ' ' ILE . 12.4 m120 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 62' ' ' ILE . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 59' ' ' ALA . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.557 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.649 HD23 HD11 ' A' ' 64' ' ' LEU . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' HD21 ' A' ' 107' ' ' LEU . 8.6 mmt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.715 0.293 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.11 61.54 4.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.424 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 18.0 t-20 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.635 ' ND2' ' O ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.563 HD13 ' N ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.659 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -28.8 8.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.8 -22.27 6.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.05 -26.56 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.46 -2.25 5.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -117.54 159.89 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.764 0.316 . . . . 0.0 110.764 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 6.1 m-85 -106.46 157.9 17.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t -133.23 122.06 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.574 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.619 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.6 m120 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 62' ' ' ILE . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 75' ' ' LEU . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.54 HG22 ' OD1' ' A' ' 92' ' ' ASN . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 64' ' ' LEU . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' ILE . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.992 HD11 HG22 ' A' ' 62' ' ' ILE . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.7 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.54 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HA ' HD22 ' A' ' 107' ' ' LEU . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.519 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.65 62.8 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.805 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 11' ' ' ILE . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.59 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.688 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.691 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.805 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -37.79 4.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.73 -27.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.05 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.76 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.39 6.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.665 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.52 165.56 10.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.884 0.373 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -106.05 157.82 17.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.004 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.51 121.61 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.397 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.8 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' ND2' HD22 ' A' ' 79' ' ' LEU . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.1 m120 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HD11 ' A' ' 62' ' ' ILE . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.706 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.924 HG22 HD11 ' A' ' 75' ' ' LEU . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 73' ' ' PRO . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.789 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 62' ' ' ILE . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' ' 59' ' ' ALA . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.703 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 64' ' ' LEU . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.8 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 121.195 0.331 . . . . 0.13 112.599 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.23 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 1.19 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.587 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.17 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.14 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.28 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.759 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.21 110.966 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.59 110.651 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.24 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.21 110.724 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.21 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.28 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.2 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.19 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.23 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.664 ' CD1' HD13 ' A' ' 93' ' ' LEU . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 1.39 111.052 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.21 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.759 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.23 111.244 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.13 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.24 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.29 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.795 0.331 . . . . 0.28 111.264 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.859 ' HB2' HD23 ' A' ' 104' ' ' LEU . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.7 110.767 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 20' ' ' HIS . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.24 111.025 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 40' ' ' TYR . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.51 110.982 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 0.16 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.16 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 1.18 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 1.28 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 0.16 111.124 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' ND2' HD22 ' A' ' 79' ' ' LEU . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.87 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.18 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.09 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.12 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.1 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.05 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.641 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 1.21 110.788 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.21 111.072 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.23 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.23 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.22 111.076 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.08 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.925 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.692 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.21 111.069 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 93' ' ' LEU . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.929 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.27 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.93 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.4 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.67 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.35 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.587 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 0.18 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.468 ' CB ' HD21 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.23 112.308 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.99 111.237 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.81 HD11 HG22 ' A' ' 62' ' ' ILE . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.23 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 1.65 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.19 111.131 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.12 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.16 111.061 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.52 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 1.63 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.92 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.64 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.83 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.54 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.29 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.57 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.929 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.13 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' LEU . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.14 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.08 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.11 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.653 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.39 111.513 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.1 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.09 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.16 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.17 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.29 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.15 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 0.22 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.859 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.23 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.16 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 1.23 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 96' ' ' ARG . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.29 110.871 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.17 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.342 0 CA-C-O 121.239 0.355 . . . . 0.0 112.226 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.656 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.7 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.403 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.508 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.784 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.7 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 20' ' ' HIS . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.931 HG22 HD11 ' A' ' 75' ' ' LEU . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.677 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.656 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HB2' HD21 ' A' ' 64' ' ' LEU . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.501 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.931 HD11 HG22 ' A' ' 62' ' ' ILE . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 59' ' ' ALA . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 33' ' ' SER . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.291 0 CA-C-O 121.151 0.306 . . . . 0.0 112.525 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.569 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.541 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 4.4 t30 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.554 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.517 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.467 ' HA ' HD12 ' A' ' 37' ' ' LEU . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.663 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.822 0.344 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.878 ' HB2' HD23 ' A' ' 104' ' ' LEU . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 20' ' ' HIS . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.632 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.778 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 75' ' ' LEU . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 74' ' ' VAL . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.458 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CB ' HD21 ' A' ' 64' ' ' LEU . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 62' ' ' ILE . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.437 ' NH2' HG11 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.344 0 CA-C-O 121.131 0.295 . . . . 0.0 112.668 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.538 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.405 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.488 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.629 HD12 HD13 ' A' ' 93' ' ' LEU . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.804 0.335 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 75' ' ' LEU . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 93' ' ' LEU . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.59 ' CB ' HD21 ' A' ' 64' ' ' LEU . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 62' ' ' ILE . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.724 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.408 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 81' ' ' PRO . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.55 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 19' ' ' LEU . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 121.152 0.306 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.746 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.443 ' OD1' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 25' ' ' ASN . 11.5 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.798 0.332 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.734 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 37' ' ' LEU . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CE2' HD13 ' A' ' 62' ' ' ILE . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.872 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 73' ' ' PRO . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.684 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.872 HD11 HG22 ' A' ' 62' ' ' ILE . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 59' ' ' ALA . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.667 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.806 HD13 HD12 ' A' ' 19' ' ' LEU . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.346 0 CA-C-O 121.268 0.371 . . . . 0.0 112.466 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.575 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.555 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 3.4 t30 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 ' C ' ' A' ' 8' ' ' SER . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.73 ' HA ' HD12 ' A' ' 37' ' ' LEU . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.854 0.359 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.438 HD22 HD22 ' A' ' 79' ' ' LEU . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.426 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 75' ' ' LEU . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.687 ' CD1' HD23 ' A' ' 93' ' ' LEU . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 71' ' ' ASN . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 72' ' ' ILE . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 62' ' ' ILE . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.783 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.687 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.501 ' C ' HD13 ' A' ' 107' ' ' LEU . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 96' ' ' ARG . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.334 0 CA-C-O 121.316 0.398 . . . . 0.0 112.594 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.478 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.708 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.402 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD12 HD13 ' A' ' 93' ' ' LEU . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.812 0.339 . . . . 0.0 111.411 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 37' ' ' LEU . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 62' ' ' ILE . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 73' ' ' PRO . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' CB ' HG21 ' A' ' 74' ' ' VAL . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.483 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.1 m-80 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.722 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.754 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.771 HD13 HD12 ' A' ' 19' ' ' LEU . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HD22 ' A' ' 107' ' ' LEU . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.337 0 CA-C-O 121.303 0.39 . . . . 0.0 112.352 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.436 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.648 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.635 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 37' ' ' LEU . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 HD13 ' A' ' 93' ' ' LEU . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.751 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 37' ' ' LEU . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.477 HD22 HD22 ' A' ' 79' ' ' LEU . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.692 ' HE2' HG21 ' A' ' 62' ' ' ILE . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HD11 ' A' ' 62' ' ' ILE . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 73' ' ' PRO . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HB2' HD21 ' A' ' 64' ' ' LEU . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD23 ' HB2' ' A' ' 59' ' ' ALA . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.715 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 19' ' ' LEU . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 121.223 0.346 . . . . 0.0 112.599 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 37' ' ' LEU . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.538 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.877 0.37 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.812 ' HB2' HD23 ' A' ' 104' ' ' LEU . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.468 ' CG ' HD22 ' A' ' 79' ' ' LEU . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD1' HD11 ' A' ' 79' ' ' LEU . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 62' ' ' ILE . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.962 HG22 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 73' ' ' PRO . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.633 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HB2' HD21 ' A' ' 64' ' ' LEU . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 72' ' ' ILE . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.962 HD11 HG22 ' A' ' 62' ' ' ILE . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.762 HD12 ' CB ' ' A' ' 89' ' ' ALA . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.762 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.449 0 CA-C-O 121.272 0.373 . . . . 0.0 112.355 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.596 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.466 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.664 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 37' ' ' LEU . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.501 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.933 HD12 HD13 ' A' ' 93' ' ' LEU . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.745 0.307 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 20' ' ' HIS . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.871 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 37' ' ' LEU . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.549 ' CG ' HD22 ' A' ' 79' ' ' LEU . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 91' ' ' VAL . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' TRP . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.627 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.596 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.593 ' C ' HD11 ' A' ' 64' ' ' LEU . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 62' ' ' ILE . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.933 HD13 HD12 ' A' ' 19' ' ' LEU . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.33 0 CA-C-O 121.236 0.354 . . . . 0.0 112.682 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.486 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.625 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 8' ' ' SER . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 37' ' ' LEU . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.501 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 13' ' ' LEU . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.482 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.857 0.361 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 79' ' ' LEU . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.429 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.603 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.84 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.761 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 73' ' ' PRO . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HA ' HG23 ' A' ' 66' ' ' ILE . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.777 HG22 ' OD1' ' A' ' 92' ' ' ASN . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HB2' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.84 HD11 HG22 ' A' ' 62' ' ' ILE . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.779 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 19' ' ' LEU . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.327 0 CA-C-O 121.326 0.404 . . . . 0.0 112.294 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.692 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.717 ' HA ' HD23 ' A' ' 64' ' ' LEU . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.682 HD12 HD13 ' A' ' 93' ' ' LEU . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.856 0.36 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.718 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 20' ' ' HIS . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' CG ' HD22 ' A' ' 79' ' ' LEU . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HE2' HG21 ' A' ' 62' ' ' ILE . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.967 HG22 HD11 ' A' ' 75' ' ' LEU . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 12' ' ' TRP . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' HD11 ' A' ' 72' ' ' ILE . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.6 m-80 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.589 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.529 ' C ' HD11 ' A' ' 64' ' ' LEU . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 72' ' ' ILE . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.967 HD11 HG22 ' A' ' 62' ' ' ILE . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.752 HD12 ' CB ' ' A' ' 89' ' ' ALA . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.752 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 19' ' ' LEU . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.379 0 CA-C-O 121.246 0.359 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.505 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD13 ' A' ' 93' ' ' LEU . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.852 0.358 . . . . 0.0 111.394 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.85 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 20' ' ' HIS . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 79' ' ' LEU . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.552 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.894 HG22 HD11 ' A' ' 75' ' ' LEU . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.642 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB2' HD21 ' A' ' 64' ' ' LEU . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.894 HD11 HG22 ' A' ' 62' ' ' ILE . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 89' ' ' ALA . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.792 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.778 HD13 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.642 ' HA ' HD22 ' A' ' 107' ' ' LEU . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.85 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-O 121.267 0.371 . . . . 0.0 112.311 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.452 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.888 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.508 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 20' ' ' HIS . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.843 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.829 0.347 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB2' HD23 ' A' ' 104' ' ' LEU . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.92 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 37' ' ' LEU . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.878 HG22 HD11 ' A' ' 75' ' ' LEU . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.681 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.577 HD21 ' CB ' ' A' ' 73' ' ' PRO . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.649 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.54 ' HA ' HG23 ' A' ' 66' ' ' ILE . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HG22 ' A' ' 62' ' ' ILE . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.778 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 89' ' ' ALA . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.765 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.534 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' HD22 ' A' ' 107' ' ' LEU . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-O 121.19 0.328 . . . . 0.0 112.623 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 5.5 t30 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.541 ' O ' HD22 ' A' ' 19' ' ' LEU . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.482 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.679 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.809 0.338 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.765 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.601 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 75' ' ' LEU . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 73' ' ' PRO . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 71' ' ' ASN . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 66' ' ' ILE . 20.3 m-80 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.593 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HB2' HD21 ' A' ' 64' ' ' LEU . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.573 ' C ' HD12 ' A' ' 64' ' ' LEU . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 62' ' ' ILE . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.759 HD12 ' CB ' ' A' ' 89' ' ' ALA . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 46' ' ' GLY . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.759 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.509 HD23 ' CD1' ' A' ' 64' ' ' LEU . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.765 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.333 0 CA-C-O 121.198 0.332 . . . . 0.0 112.567 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.589 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 4.3 t30 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.473 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.767 0.318 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 20' ' ' HIS . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 79' ' ' LEU . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HE2' HG21 ' A' ' 62' ' ' ILE . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 75' ' ' LEU . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' CD1' HD23 ' A' ' 93' ' ' LEU . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 70' ' ' ASP . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.612 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 62' ' ' ILE . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.821 HD23 ' HB2' ' A' ' 59' ' ' ALA . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.694 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.318 0 CA-C-O 121.267 0.371 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.545 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.596 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t30 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 8' ' ' SER . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 93' ' ' LEU . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 111.391 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.928 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.49 ' CG ' HD22 ' A' ' 79' ' ' LEU . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 79' ' ' LEU . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.99 HG22 HD11 ' A' ' 75' ' ' LEU . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 ' HB2' ' A' ' 73' ' ' PRO . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 66' ' ' ILE . 21.5 m-80 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.679 ' HB2' HD21 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 64' ' ' LEU . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 62' ' ' ILE . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 88' ' ' GLU . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 87' ' ' VAL . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 19' ' ' LEU . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 107' ' ' LEU . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.502 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 CA--C 1.509 -0.319 0 CA-C-O 121.271 0.373 . . . . 0.0 112.56 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.517 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.621 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.513 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.813 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.782 0.325 . . . . 0.0 111.296 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.703 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.452 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 75' ' ' LEU . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 93' ' ' LEU . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 62' ' ' ILE . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 59' ' ' ALA . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.557 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.649 HD23 HD11 ' A' ' 64' ' ' LEU . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.305 0 CA-C-O 121.229 0.349 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.519 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 4.3 t30 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.563 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.659 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.872 0.367 . . . . 0.0 111.574 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.619 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 62' ' ' ILE . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 75' ' ' LEU . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.54 HG22 ' OD1' ' A' ' 92' ' ' ASN . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 64' ' ' LEU . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' ILE . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.992 HD11 HG22 ' A' ' 62' ' ' ILE . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.7 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.54 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HA ' HD22 ' A' ' 107' ' ' LEU . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.519 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . . . . . . 0 N--CA 1.451 -0.35 0 CA-C-O 121.219 0.344 . . . . 0.0 112.548 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' HIS . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.805 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.59 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.688 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.691 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.805 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.804 0.335 . . . . 0.0 111.397 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.8 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.545 ' ND2' HD22 ' A' ' 79' ' ' LEU . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HD11 ' A' ' 62' ' ' ILE . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.706 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.924 HG22 HD11 ' A' ' 75' ' ' LEU . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 73' ' ' PRO . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.789 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 62' ' ' ILE . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' ' 59' ' ' ALA . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.703 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.582 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 64' ' ' LEU . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.8 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.82 0.343 . . . . 3.27 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -92.51 62.66 2.35 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.773 . . . . 0.13 112.599 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -61.39 -15.28 35.04 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.229 -0.485 . . . . 2.23 110.843 178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.67 -32.78 2.57 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 116.602 -0.272 . . . . 1.19 111.317 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.587 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.0 p80 -62.19 -35.87 80.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.85 0.357 . . . . 0.17 110.616 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -22.47 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.01 -0.541 . . . . 1.14 111.248 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -110.34 14.84 22.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.349 -0.387 . . . . 1.28 111.355 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.759 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.8 t -127.65 154.65 45.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.882 0.372 . . . . 0.21 110.966 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -119.79 159.78 23.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.001 -0.545 . . . . 1.59 110.651 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.9 m-20 57.96 58.62 3.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.993 -0.548 . . . . 2.24 110.887 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -93.29 116.95 35.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 0.21 110.724 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.419 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.0 p-90 -162.0 -173.15 3.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.305 -0.407 . . . . 0.21 110.933 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -131.9 146.04 51.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.28 111.087 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.4 tt0 -119.42 118.81 32.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 1.14 110.7 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 61.38 17.82 8.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.035 -0.53 . . . . 0.93 111.287 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.66 56.3 25.67 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.794 -0.717 . . . . 0.2 112.963 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -31.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.579 0.228 . . . . 0.19 111.445 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.5 mm -102.55 130.93 51.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.23 110.957 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.664 ' CD1' HD13 ' A' ' 93' ' ' LEU . 9.2 tt -111.35 140.34 46.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 1.39 111.052 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.588 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.18 136.19 45.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 0.21 110.399 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.759 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.2 145.08 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.23 111.244 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -99.91 97.83 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 2.13 110.734 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.1 m -101.31 132.95 46.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.24 110.998 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.94 -178.49 47.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.29 112.461 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.25 -33.38 5.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.786 0.327 . . . . 0.38 110.926 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.41 -26.41 2.56 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.697 -0.763 . . . . 0.63 112.446 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.93 -28.61 67.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.747 0.308 . . . . 2.76 110.918 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.91 -3.87 6.05 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.742 . . . . 0.7 112.859 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -105.29 163.4 12.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.865 0.364 . . . . 1.26 110.88 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.4 m-30 -104.48 157.05 17.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 1.3 110.825 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.1 t -135.23 114.51 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.282 -0.417 . . . . 0.28 111.264 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -65.72 121.16 14.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 1.58 111.036 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.859 ' HB2' HD23 ' A' ' 104' ' ' LEU . 5.1 m -136.76 160.06 39.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.7 110.767 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 20' ' ' HIS . 68.2 p -142.39 155.22 45.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.329 -0.396 . . . . 0.24 111.025 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 40' ' ' TYR . 1.1 tp -137.67 141.1 41.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.51 110.982 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 62.8 t0 -96.78 123.53 40.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.639 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -28.16 21.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.049 -0.523 . . . . 0.16 110.736 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -57.1 -12.75 2.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.831 -0.622 . . . . 1.16 110.61 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.6 3.47 5.55 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.274 -0.421 . . . . 1.18 111.512 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.55 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.66 -27.41 5.88 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.575 -0.284 . . . . 1.28 111.077 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.7 mt -121.54 143.45 33.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.889 0.376 . . . . 0.16 111.124 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.88 177.2 18.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.848 -0.691 . . . . 0.13 112.423 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' ND2' HD22 ' A' ' 79' ' ' LEU . 62.2 t-20 -102.52 111.2 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.62 110.939 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -111.76 98.15 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 1.19 110.83 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.0 t70 60.67 46.32 9.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.781 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.74 17.85 73.52 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 0.13 112.644 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.6 163.03 25.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.846 0.355 . . . . 0.87 110.851 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -80.5 140.63 35.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.118 -0.492 . . . . 1.18 110.888 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.94 125.86 34.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.235 -0.439 . . . . 1.28 111.013 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.9 m95 -74.96 119.27 18.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.09 110.845 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.04 10.79 38.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.691 -0.766 . . . . 0.12 112.719 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.32 -149.21 25.39 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.66 -0.781 . . . . 0.1 112.273 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.1 pt-20 -178.7 156.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.922 0.391 . . . . 1.49 111.02 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 64.71 28.11 13.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.036 -0.529 . . . . 1.05 111.024 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.641 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.8 p90 -59.56 -40.48 87.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.338 -0.392 . . . . 1.21 110.788 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 13.1 t -68.83 -24.03 64.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.07 -0.514 . . . . 0.21 111.072 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.13 -25.93 11.58 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.765 -0.731 . . . . 0.23 112.665 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.79 28.82 5.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.762 0.315 . . . . 1.23 110.887 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.82 169.38 12.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.22 111.076 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.9 m -139.27 150.5 45.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 1.08 110.95 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.53 63.69 0.96 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.38 111.69 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.81 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -87.12 116.77 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.18 110.925 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.692 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.24 159.79 41.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.334 -0.394 . . . . 0.21 111.069 -179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD13 HD11 ' A' ' 93' ' ' LEU . 8.9 tp -108.27 129.57 55.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.33 110.929 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -128.46 153.95 46.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.946 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 mm -84.94 139.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.27 110.667 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.23 129.52 19.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 1.93 110.878 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 104.24 164.06 24.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.699 -0.762 . . . . 0.4 112.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -77.17 -15.28 59.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.604 0.24 . . . . 1.67 111.235 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.503 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -91.43 -4.59 55.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.619 -0.264 . . . . 1.21 111.386 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 65.67 77.46 0.3 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.972 0.415 . . . . 0.35 110.633 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.587 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -108.01 117.48 55.01 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.908 -0.587 . . . . 0.18 111.161 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.468 ' CB ' HD21 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.58 102.54 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.529 2.153 . . . . 0.23 112.308 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -106.3 125.73 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.99 111.237 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.81 HD11 HG22 ' A' ' 62' ' ' ILE . 27.8 tp -92.98 117.21 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.23 110.819 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -117.61 133.25 56.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.454 . . . . 1.65 111.004 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.03 146.16 6.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.19 111.131 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.59 112.2 9.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.12 110.811 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.738 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.3 mt -97.93 151.65 20.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.16 111.061 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -101.81 108.7 57.22 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.52 110.703 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.77 167.51 26.92 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.496 2.131 . . . . 0.26 112.387 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -77.71 -22.29 50.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 1.63 111.045 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.01 -41.55 59.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.322 -0.399 . . . . 1.92 110.878 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.48 157.26 7.51 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.666 -0.778 . . . . 0.64 112.511 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 62.7 114.57 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.541 0.21 . . . . 1.83 110.84 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.03 142.98 63.87 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.401 2.067 . . . . 0.54 112.243 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.1 m -122.23 145.22 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 1.29 111.133 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.6 114.53 5.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 1.57 110.881 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.738 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.49 143.97 32.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.13 110.929 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.48 122.61 15.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.16 110.911 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.04 134.09 61.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.13 111.158 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -89.16 109.22 20.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.071 -0.513 . . . . 0.23 110.351 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.664 HD13 ' CD1' ' A' ' 19' ' ' LEU . 55.9 mt -49.31 -39.23 30.43 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.998 0.428 . . . . 1.14 110.846 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.5 m -60.01 -13.73 12.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.94 -0.573 . . . . 1.08 111.408 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -59.91 -47.33 86.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.678 0.275 . . . . 1.11 111.221 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.653 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.5 mmm180 -140.5 40.26 1.88 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.464 -0.335 . . . . 0.39 111.513 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.1 mm -124.71 117.9 51.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.764 0.316 . . . . 0.1 110.481 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -177.15 16.66 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.534 -0.841 . . . . 0.09 112.894 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -135.29 104.18 5.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.16 110.757 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -93.84 116.93 29.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.24 -0.437 . . . . 1.17 110.984 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.6 t 54.81 30.5 13.82 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.29 110.985 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.17 -15.47 61.95 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.15 112.671 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 43.2 m -86.52 145.36 26.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.847 0.355 . . . . 0.22 110.893 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.859 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -73.02 128.62 35.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.23 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -135.24 167.47 25.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.16 111.129 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -118.91 138.48 52.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 1.23 110.637 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 96' ' ' ARG . 8.6 mp -68.04 106.44 2.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 1.29 110.871 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.228 -0.891 . . . . 1.17 111.087 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.746 0.307 . . . . 0.0 111.247 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -78.79 62.37 3.92 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.226 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 30.7 p30 -60.97 -15.03 26.86 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.08 -0.56 . . . . 0.0 111.008 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.46 -33.46 2.66 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.776 0.322 . . . . 0.0 111.301 -178.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.656 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -64.13 -37.36 87.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.827 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -24.74 50.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.3 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.5 p -109.54 18.08 20.7 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.48 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.7 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 t -129.87 156.45 44.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.857 0.36 . . . . 0.0 110.934 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -120.64 159.77 24.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.683 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.403 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 7.2 m-20 57.94 59.55 3.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.987 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -93.1 116.86 35.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.49 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.508 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.8 p-90 -160.68 -171.9 3.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -135.26 145.47 47.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.06 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -116.95 121.42 41.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.625 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.66 18.16 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.16 -179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.31 57.21 20.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.046 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 9.9 p-80 -175.95 -30.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.528 0.204 . . . . 0.0 111.457 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -101.49 130.4 51.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 111.048 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.784 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -108.97 139.66 43.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.925 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.784 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.3 134.16 35.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.523 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.7 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.47 137.77 5.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.144 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -89.58 97.76 11.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.669 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 24.4 m -101.85 133.79 46.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 111.107 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.4 177.59 50.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -28.62 7.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.746 0.308 . . . . 0.0 110.958 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 135.24 -28.09 3.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.406 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.85 -26.25 66.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.759 0.314 . . . . 0.0 110.951 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.1 7.22 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.938 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.58 161.31 16.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.817 0.342 . . . . 0.0 110.993 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -103.91 157.86 16.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.843 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.86 125.8 46.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.665 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.72 115.13 10.55 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.642 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.6 m -134.64 165.53 25.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.668 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 20' ' ' HIS . 37.8 p -146.53 154.65 41.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.204 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.31 136.83 47.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 8.1 t70 -97.06 122.43 40.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 0.0 110.709 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.934 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.75 20.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.76 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -57.02 -13.43 2.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.511 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.66 3.55 6.12 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.469 179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 m-30 -117.99 -29.69 5.56 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.728 0.299 . . . . 0.0 110.917 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.781 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.7 mt -119.87 141.95 37.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.4 175.47 18.57 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.764 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -92.3 106.51 18.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -111.93 97.79 6.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.678 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.7 t70 55.61 47.18 21.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.863 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.29 18.82 69.84 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.627 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.7 t -128.78 160.16 33.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.827 0.346 . . . . 0.0 110.974 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.2 m-85 -78.72 139.24 38.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.844 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.02 127.94 39.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.061 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.42 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.4 m95 -77.07 116.15 17.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.783 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.3 8.37 29.16 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.695 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.87 -152.23 28.62 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.351 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.411 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -177.77 155.45 1.02 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 69.12 27.46 5.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.023 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.6 p90 -60.01 -44.42 94.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.854 0.359 . . . . 0.0 110.806 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.58 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.4 t -62.9 -17.95 62.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.11 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.18 -40.33 21.36 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.68 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -121.93 31.68 6.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.964 179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.72 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.47 160.43 23.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.933 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.9 m -135.2 151.52 50.71 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.68 61.54 1.4 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.734 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.931 HG22 HD11 ' A' ' 75' ' ' LEU . 6.6 mt -85.95 121.0 36.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.622 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.677 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.2 157.62 44.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 0.0 111.28 -179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.538 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.8 tp -105.69 130.25 53.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.93 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.46 153.91 46.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.471 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.9 mm -84.99 144.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.681 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.57 128.98 14.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.5 160.0 26.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.529 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.3 -16.89 62.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.617 0.246 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.38 -6.61 57.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.37 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.471 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.7 m-80 66.24 75.77 0.32 Allowed 'General case' 0 CA--C 1.52 -0.189 0 CA-C-O 121.094 0.474 . . . . 0.0 110.732 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.656 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.2 mm -103.22 122.67 44.45 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.06 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.538 ' HB2' HD21 ' A' ' 64' ' ' LEU . 44.6 Cg_endo -68.01 102.49 0.78 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.473 2.116 . . . . 0.0 112.339 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.501 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.3 t -106.57 127.19 62.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.32 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.931 HD11 HG22 ' A' ' 62' ' ' ILE . 66.2 tp -95.92 116.14 28.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.748 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.2 mtm180 -114.3 132.05 56.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.031 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.607 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.22 147.69 6.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.186 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -78.49 117.31 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.599 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.72 HD23 ' HB2' ' A' ' 59' ' ' ALA . 38.4 mt -104.9 150.63 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.263 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.54 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 19.6 m-80 -92.74 108.36 31.27 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.694 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -73.74 166.64 29.23 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.406 2.071 . . . . 0.0 112.26 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 8.2 ptm -75.63 -23.04 56.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.034 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.84 -50.77 18.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.864 0.364 . . . . 0.0 110.89 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.9 152.88 5.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.552 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.9 t70 63.85 124.24 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 120.512 0.196 . . . . 0.0 110.786 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -68.63 145.94 65.53 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.379 2.053 . . . . 0.0 112.242 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -124.24 148.38 28.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -69.33 113.07 6.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.671 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 141.26 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.95 122.35 17.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.94 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.26 135.82 58.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.555 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.6 t30 -91.31 108.84 20.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.399 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 72.5 mt -48.99 -38.84 24.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.961 0.41 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.41 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.3 p -60.06 -13.53 12.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.293 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.96 -46.96 88.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.71 0.291 . . . . 0.0 111.408 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.1 mmm180 -139.84 39.5 1.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.434 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.92 117.88 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.747 0.308 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.418 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.91 -175.41 16.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.692 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.6 103.33 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.779 0.323 . . . . 0.0 110.849 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -94.47 116.84 29.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.2 t 55.57 30.59 15.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.977 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.56 -13.39 65.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.738 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 53.0 m -87.1 144.18 26.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.025 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.642 HD23 ' HB2' ' A' ' 33' ' ' SER . 2.1 mm? -72.99 122.93 22.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.727 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -129.14 169.83 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.323 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -121.34 138.39 54.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.534 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.32 102.33 1.37 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.11 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.21 61.68 1.85 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.525 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -59.84 -15.33 20.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.866 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.57 -33.33 2.73 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-O 120.676 0.274 . . . . 0.0 111.305 -178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.569 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.1 p80 -61.68 -35.78 78.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.665 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -22.59 38.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.77 14.13 22.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.541 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 27.7 t -123.4 157.06 34.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 110.861 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.412 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 4.4 t30 -122.48 159.93 26.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.35 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.554 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 57.53 58.1 3.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.714 0.769 . . . . 0.0 110.604 -179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.517 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -93.22 116.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.718 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.544 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.89 -175.22 4.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.9 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -133.55 142.55 48.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.009 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.3 tt0 -114.03 120.02 39.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.645 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.58 17.78 7.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.51 56.02 26.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.132 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.467 ' HA ' HD12 ' A' ' 37' ' ' LEU . 9.9 p-80 -175.45 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.672 0.236 . . . . 0.0 111.572 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 13' ' ' LEU . 27.1 mm -101.44 129.91 51.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.922 0.391 . . . . 0.0 111.064 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.663 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -108.93 137.67 46.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.854 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.663 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.33 131.49 32.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.644 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.541 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.27 146.59 4.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' GLU . 5.9 pt-20 -106.08 108.31 19.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.927 0.394 . . . . 0.0 110.83 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -105.84 152.19 23.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.859 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -86.81 170.3 41.69 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.374 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.51 -38.33 4.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 0.0 110.737 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.8 -23.2 2.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.995 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -27.84 69.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.87 0.367 . . . . 0.0 110.993 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.49 1.78 7.05 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.695 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -122.21 163.89 18.79 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.846 0.355 . . . . 0.0 110.788 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 3.9 m-85 -104.64 157.89 16.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.979 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -133.64 119.73 34.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.523 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 15.6 tt0 -67.46 118.3 10.6 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.97 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.878 ' HB2' HD23 ' A' ' 104' ' ' LEU . 37.0 m -129.87 161.56 30.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 20' ' ' HIS . 75.6 p -140.8 145.76 36.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.126 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -100.4 122.63 43.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.574 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.975 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -28.39 20.79 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.826 179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -57.18 -12.65 2.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.698 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.34 2.3 5.7 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.56 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.87 -28.22 5.99 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.636 0.255 . . . . 0.0 111.075 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.83 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.0 mt -119.48 142.57 34.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.92 175.88 18.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.6 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 21.3 t-20 -93.86 109.15 20.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.78 0.324 . . . . 0.0 110.912 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -111.78 97.91 7.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.71 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 55.9 50.44 13.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.27 17.19 65.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.8 t -128.85 163.88 24.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.812 0.339 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.537 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.3 m-85 -80.17 141.12 35.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.808 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.9 127.51 38.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.016 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 31.5 m95 -76.88 117.58 18.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.813 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.28 9.68 33.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.67 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.92 -149.88 26.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.191 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 5.0 pt-20 -179.4 156.61 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.885 0.374 . . . . 0.0 111.052 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 65.52 29.08 11.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.632 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.9 p90 -60.86 -40.72 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 25.3 t -62.65 -27.16 69.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.035 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.43 -25.93 21.37 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.583 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.73 29.24 5.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.766 0.317 . . . . 0.0 110.786 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.778 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.66 162.25 28.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.104 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.7 m -134.68 153.81 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.869 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 61.97 1.25 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.607 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 75' ' ' LEU . 11.9 mt -86.36 114.2 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.01 159.14 42.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.076 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 74' ' ' VAL . 18.7 tp -105.17 129.93 53.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.023 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -128.51 153.85 46.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.458 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -84.91 145.15 8.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.698 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -147.95 136.42 21.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.79 162.22 36.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.536 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.45 -7.01 52.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.571 0.224 . . . . 0.0 111.392 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.539 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -96.86 -8.03 31.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.348 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.2 m-80 66.99 79.06 0.24 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.984 0.421 . . . . 0.0 110.65 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.569 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.1 mm -109.34 126.39 29.35 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.213 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.446 ' CB ' HD21 ' A' ' 64' ' ' LEU . 40.5 Cg_endo -67.21 102.63 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.508 2.139 . . . . 0.0 112.395 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.5 ' C ' HD12 ' A' ' 64' ' ' LEU . 21.2 t -108.15 120.25 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.262 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 62' ' ' ILE . 28.6 tp -90.34 119.5 30.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.795 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.437 ' NH2' HG11 ' A' ' 74' ' ' VAL . 0.9 OUTLIER -116.92 133.4 56.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.17 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.658 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.16 144.98 5.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.196 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -74.06 106.19 5.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.657 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 40.7 mt -92.09 152.03 20.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.324 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -104.77 110.79 64.9 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.526 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 69.9 Cg_endo -74.11 167.51 27.03 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.491 2.127 . . . . 0.0 112.409 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.5 ptt? -76.71 -22.88 53.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.96 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.08 -35.79 59.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 130.75 160.66 10.05 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.88 109.41 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.522 0.201 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.52 145.09 69.45 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.426 2.084 . . . . 0.0 112.208 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.8 m -126.41 149.19 31.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.54 116.18 6.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.75 144.37 33.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.979 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.902 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.537 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -132.22 136.32 56.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' VAL . 1.9 t30 -92.7 108.71 20.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 57.8 mt -49.14 -38.98 27.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.947 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.1 p -60.65 -13.46 14.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.425 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -60.38 -46.43 89.98 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.697 0.284 . . . . 0.0 111.424 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -139.48 39.94 2.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.45 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.479 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.5 mm -124.74 118.1 52.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.78 0.324 . . . . 0.0 110.573 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.43 -179.42 17.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.814 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -131.64 101.2 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.839 0.352 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -92.2 116.87 29.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.976 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.4 t 54.78 30.69 14.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.18 -14.14 64.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.643 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.5 m -87.22 144.93 26.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.878 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.9 OUTLIER -73.53 123.54 24.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.49 175.02 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.71 138.47 54.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.664 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.93 100.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.055 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.815 0.341 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -96.06 63.2 1.25 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.668 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.41 -15.36 48.71 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.31 -0.445 . . . . 0.0 110.777 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.76 -32.87 2.72 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.713 0.292 . . . . 0.0 111.315 -178.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.8 p80 -62.27 -36.59 82.53 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.722 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -24.16 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.201 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -109.02 16.28 22.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.438 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.538 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 22.6 t -128.27 161.37 29.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.964 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -126.46 159.8 32.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.405 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 24.6 m-20 58.07 58.97 3.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.922 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.2 mm -93.56 116.87 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.566 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -162.88 -171.41 2.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.953 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 37' ' ' LEU . 7.6 tp -134.06 147.56 50.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.107 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 39.8 tt0 -118.54 119.6 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.678 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 61.24 17.33 8.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.21 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.447 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.06 55.77 27.73 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.165 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.488 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.72 -31.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.673 0.236 . . . . 0.0 111.573 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.488 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.1 mm -101.79 130.76 50.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.909 0.385 . . . . 0.0 110.995 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.629 HD12 HD13 ' A' ' 93' ' ' LEU . 8.2 tt -110.57 142.81 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.045 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -138.3 133.86 33.59 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.302 179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.538 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.59 155.08 19.15 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.307 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -107.22 97.86 7.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.713 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.4 m -102.31 128.39 48.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.97 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.29 177.27 52.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.517 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.07 -28.06 7.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.339 . . . . 0.0 110.993 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 134.09 -28.05 3.23 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.396 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -65.0 -29.08 69.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.841 0.353 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.59 -2.32 6.51 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.873 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.93 163.41 13.15 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.844 0.354 . . . . 0.0 110.994 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -103.03 157.75 16.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.88 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.9 t -134.22 116.94 23.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.332 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -67.59 122.32 17.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.938 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -138.86 150.97 46.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.801 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 81.6 p -138.27 147.27 43.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.45 139.33 49.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.6 t70 -95.03 123.44 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.438 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.076 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.46 -28.05 21.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.79 179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -57.5 -12.58 2.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.661 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.33 1.06 5.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.658 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.51 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -118.13 -23.92 7.19 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.659 0.266 . . . . 0.0 111.153 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.78 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -124.4 142.13 42.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 110.989 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.2 177.83 17.46 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.502 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.2 t-20 -103.94 111.83 24.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -111.77 98.32 7.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.0 t0 60.75 45.59 9.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.17 18.31 74.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.576 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.91 158.56 37.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.87 0.367 . . . . 0.0 110.887 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.529 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.5 m-85 -75.31 141.53 43.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.05 123.89 29.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.406 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.1 m95 -74.43 120.82 20.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.81 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.59 12.42 44.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.803 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.0 -148.41 24.1 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.347 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 3.2 pt-20 -178.73 157.45 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.875 0.369 . . . . 0.0 110.997 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 65.78 27.74 11.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.026 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.517 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.0 p90 -60.73 -42.73 97.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.771 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.543 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.3 t -66.61 -23.35 66.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.025 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.08 -26.87 9.41 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.627 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 26.22 5.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.766 0.317 . . . . 0.0 110.904 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.673 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.15 160.33 28.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.932 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.5 m -134.48 151.59 51.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.52 64.34 0.86 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.618 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.001 HG22 HD11 ' A' ' 75' ' ' LEU . 3.4 mt -89.65 123.55 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.845 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.683 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -143.98 159.78 42.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.106 -179.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.594 HD13 HD11 ' A' ' 93' ' ' LEU . 6.5 tp -107.63 128.0 54.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.947 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -128.51 153.89 46.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.019 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.1 mm -84.92 144.49 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.601 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.44 134.09 17.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.899 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.64 160.87 31.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.526 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.29 -14.18 61.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.609 0.242 . . . . 0.0 111.289 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.4 m-20 -90.11 -9.07 49.72 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.403 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.428 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.0 m-80 65.62 75.45 0.35 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.01 0.433 . . . . 0.0 110.596 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.588 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -106.67 115.77 60.01 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.59 ' CB ' HD21 ' A' ' 64' ' ' LEU . 21.8 Cg_endo -61.2 102.64 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.425 2.083 . . . . 0.0 112.156 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 24.2 t -105.05 128.33 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.434 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.001 HD11 HG22 ' A' ' 62' ' ' ILE . 42.5 tp -95.3 116.07 28.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.608 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.94 135.92 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.161 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.824 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.01 149.2 7.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.15 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.88 105.64 9.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.703 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.724 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.1 mt -92.57 151.98 19.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.234 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -102.85 110.22 62.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.408 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.3 Cg_endo -74.17 167.69 26.59 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.587 2.192 . . . . 0.0 112.453 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.2 ptm -76.3 -22.68 54.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.227 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 81' ' ' PRO . 9.5 p-10 -76.05 -40.87 52.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.9 0.381 . . . . 0.0 110.986 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.45 157.46 7.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.501 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 63.46 113.2 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.578 0.228 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.408 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 42.0 Cg_endo -67.45 146.4 74.41 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.402 2.068 . . . . 0.0 112.252 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.86 149.35 30.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -65.54 112.57 3.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.813 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.724 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 142.49 35.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.005 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.27 127.15 20.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -134.35 132.96 55.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.155 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.55 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -88.16 108.3 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.4 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.629 HD13 HD12 ' A' ' 19' ' ' LEU . 60.1 mt -49.0 -38.8 24.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 1.2 m -59.94 -13.53 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.0 -46.77 89.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.692 0.282 . . . . 0.0 111.265 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.4 mmm180 -140.48 39.59 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.508 -179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.4 mm -124.77 118.01 51.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.766 0.317 . . . . 0.0 110.4 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.445 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.79 -178.35 16.81 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.937 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -134.07 100.18 4.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.8 0.333 . . . . 0.0 110.621 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -91.42 116.9 29.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 t 56.06 29.4 14.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.82 -12.39 68.97 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.688 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.3 m -88.3 146.44 25.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.833 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -73.46 126.26 29.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.025 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.6 pt -134.76 173.33 14.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.61 138.51 54.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.708 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.04 102.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.856 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.996 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.782 0.325 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.472 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -93.17 61.83 2.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 -60.35 -15.31 24.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.863 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.496 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.68 -33.0 2.68 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.618 0.247 . . . . 0.0 111.333 -178.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.518 ' CE1' HD13 ' A' ' 72' ' ' ILE . 1.9 p80 -62.36 -36.15 81.35 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.54 -23.38 40.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.164 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.42 13.89 25.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.351 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.746 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 41.6 t -127.08 155.51 43.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 110.904 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.37 159.77 24.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.604 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m-20 57.06 60.47 2.97 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -93.11 116.89 35.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.653 179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.45 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.6 p-90 -159.15 -173.42 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.975 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -134.3 145.43 49.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.9 tt0 -116.93 121.2 40.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.706 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.31 18.81 7.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.272 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 58.7 56.45 25.21 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.96 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.2 p-80 -176.37 -31.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.526 0.203 . . . . 0.0 111.423 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 24.4 mm -104.13 128.34 57.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.937 0.399 . . . . 0.0 110.954 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -108.89 142.97 38.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.005 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.473 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.28 133.22 30.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.3 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.746 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 148.25 12.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.296 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -94.82 97.81 10.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.674 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.0 m -104.77 131.91 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.108 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.48 176.56 50.2 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.374 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.443 ' OD1' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -115.8 -37.32 3.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.785 0.326 . . . . 0.0 110.868 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.79 -24.98 1.95 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.66 -27.1 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 110.984 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.85 1.37 8.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.554 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.37 164.46 13.91 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.828 0.347 . . . . 0.0 110.755 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.3 m-30 -103.96 154.93 19.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.967 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' OD1' ' A' ' 25' ' ' ASN . 11.5 t -133.31 133.47 57.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.171 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.94 113.07 16.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.578 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.734 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.12 168.95 10.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.999 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 82.0 p -151.32 153.03 34.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.896 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.09 139.66 30.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 12.8 t70 -98.28 123.25 42.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.917 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.48 -29.23 20.3 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.756 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -57.66 -12.02 2.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.69 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.99 -0.04 5.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.575 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.494 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.3 m-30 -117.49 -22.62 8.07 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.656 0.265 . . . . 0.0 111.12 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.863 HD12 ' HB3' ' A' ' 37' ' ' LEU . 19.5 mt -123.11 140.26 47.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.768 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.55 178.97 16.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.823 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' ND2' ' OG ' ' A' ' 58' ' ' SER . 24.6 t-20 -98.19 109.73 22.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.788 0.328 . . . . 0.0 110.955 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -111.97 97.79 6.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.713 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 54.57 48.95 19.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.34 17.14 70.06 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.492 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.71 153.18 47.59 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.831 0.348 . . . . 0.0 110.681 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.563 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.7 m-85 -70.32 142.04 52.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 81.6 p -130.68 123.8 30.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.21 121.1 20.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.785 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.72 11.39 44.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.768 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -99.12 -148.8 23.73 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.326 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.2 pt-20 -179.17 159.44 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 64.07 28.03 14.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.142 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.622 ' CE2' HD13 ' A' ' 62' ' ' ILE . 26.2 p90 -61.11 -41.7 97.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.93 0.395 . . . . 0.0 110.61 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 37.9 t -63.67 -17.71 63.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.991 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.21 -40.47 14.3 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.598 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 80' ' ' ASN . 1.3 p -121.48 28.31 7.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.668 0.27 . . . . 0.0 111.005 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -120.38 157.92 28.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.827 0.346 . . . . 0.0 110.865 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.4 m -134.32 153.82 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.964 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.61 60.82 1.53 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.515 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.872 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.43 114.24 24.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.914 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.759 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.21 157.4 46.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.149 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' A' ' 73' ' ' PRO . 4.6 tp -105.23 129.02 53.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.845 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.51 153.91 46.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.951 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.488 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.0 mm -84.94 141.03 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.67 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' HB2' HG21 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -141.06 126.15 18.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.853 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.52 161.31 26.05 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.537 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.85 -7.8 54.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.552 0.215 . . . . 0.0 111.381 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.684 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -93.56 -6.65 46.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.347 -179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.488 ' HA ' HG23 ' A' ' 66' ' ' ILE . 39.7 m-80 64.96 77.55 0.31 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.974 0.416 . . . . 0.0 110.65 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.684 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.7 mm -111.64 119.94 43.66 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.14 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.1 Cg_endo -62.87 102.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.576 2.184 . . . . 0.0 112.384 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.5 t -107.66 121.44 60.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.233 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.872 HD11 HG22 ' A' ' 62' ' ' ILE . 27.0 tp -89.38 118.66 29.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 -116.99 132.18 56.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.173 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 141.77 4.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -72.94 116.8 13.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.654 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.846 HD23 ' HB2' ' A' ' 59' ' ' ALA . 39.1 mt -105.55 148.61 27.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.323 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.543 ' HB2' ' CB ' ' A' ' 58' ' ' SER . 24.6 m-80 -91.15 107.22 19.67 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.323 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.62 166.37 29.53 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.361 2.041 . . . . 0.0 112.406 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.8 ptt? -74.99 -23.68 58.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.846 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.96 -42.93 62.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.17 154.62 6.91 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.554 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.6 t70 66.05 119.24 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.483 0.183 . . . . 0.0 110.932 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.0 151.77 55.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.352 2.035 . . . . 0.0 112.03 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.5 m -135.23 140.13 45.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.147 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.51 111.75 3.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.716 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.667 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.35 140.51 38.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.901 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.56 122.29 18.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.817 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.563 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.3 p -129.75 135.04 62.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.287 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -91.34 107.83 19.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.288 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.806 HD13 HD12 ' A' ' 19' ' ' LEU . 46.8 mt -49.16 -38.29 25.11 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.941 0.4 . . . . 0.0 110.882 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.0 m -59.99 -13.73 12.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.398 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.49 -46.45 89.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.691 0.282 . . . . 0.0 111.342 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.1 mmm180 -140.19 39.98 1.93 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.501 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.496 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 28.2 mm -124.72 118.04 52.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.754 0.311 . . . . 0.0 110.51 179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.9 -178.77 16.8 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.789 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -132.13 100.74 5.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.839 0.352 . . . . 0.0 110.701 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -93.16 117.9 30.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.03 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.4 t 55.92 30.3 15.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.944 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.72 -11.11 69.67 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.687 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.6 m -89.02 148.21 23.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.734 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.4 OUTLIER -75.6 126.23 30.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.9 pt -135.66 170.21 19.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.13 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -125.39 138.34 54.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.658 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 9.4 mp -68.05 101.27 1.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.093 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' HD21 ' A' ' 107' ' ' LEU . 3.3 mtp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.804 0.335 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -89.46 61.32 3.57 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.466 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -61.01 -15.2 29.12 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.094 -0.553 . . . . 0.0 110.896 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.525 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -45.77 -32.94 2.76 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.386 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.575 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -61.81 -34.58 76.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.861 0.362 . . . . 0.0 110.738 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.88 -23.0 36.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.144 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 m -110.49 14.51 22.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.481 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.555 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.6 t -124.31 154.89 39.61 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.81 0.338 . . . . 0.0 110.935 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.418 ' ND2' ' HB3' ' A' ' 10' ' ' ASN . 3.4 t30 -120.44 159.8 24.4 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.284 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.552 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.4 OUTLIER 56.21 60.06 3.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.754 0.788 . . . . 0.0 110.448 -179.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.493 HD11 ' C ' ' A' ' 8' ' ' SER . 1.3 mm -93.77 116.88 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.639 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.464 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 5.9 p-90 -162.08 -174.23 4.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.931 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.762 HD11 HD11 ' A' ' 37' ' ' LEU . 9.5 tp -137.51 139.74 40.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.171 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 59.5 tt0 -108.55 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.599 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.466 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 60.5 18.73 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.275 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.81 56.08 26.81 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.129 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.73 ' HA ' HD12 ' A' ' 37' ' ' LEU . 6.4 p-80 -176.54 -31.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.643 0.259 . . . . 0.0 111.397 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 27.6 mm -104.81 115.84 47.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.88 0.372 . . . . 0.0 110.878 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 7.6 tt -99.96 142.89 30.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.065 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.464 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -138.29 134.55 34.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.404 179.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.01 149.32 5.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.717 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -108.95 111.71 23.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -107.52 151.74 25.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.927 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.432 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -89.88 170.23 36.15 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.381 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.03 -38.13 4.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.845 0.355 . . . . 0.0 110.777 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 140.37 -22.66 2.72 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.076 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.57 -26.4 68.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 0.0 111.043 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.35 1.8 7.74 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.585 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -122.28 163.8 19.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.796 0.332 . . . . 0.0 110.669 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.432 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 4.6 m-85 -106.23 157.87 17.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.6 128.16 57.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.253 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -72.72 132.8 44.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.775 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -140.65 156.5 46.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 26.6 p -142.69 143.86 32.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.42 138.13 50.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.127 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 31.3 t0 -99.73 124.26 44.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.652 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.828 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.51 -27.83 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -56.75 -12.24 1.79 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.668 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.93 2.55 5.33 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.57 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.5 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.96 -22.72 6.62 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.183 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.9 mt -126.61 143.02 41.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 111.04 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.16 -179.89 16.37 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.615 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.438 HD22 HD22 ' A' ' 79' ' ' LEU . 21.7 t-20 -97.9 109.77 22.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.35 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -111.8 97.94 7.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.757 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.4 t70 55.93 48.2 18.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.966 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.18 17.84 70.51 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.577 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.87 163.43 24.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.897 0.38 . . . . 0.0 110.86 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.64 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.9 m-85 -82.99 140.18 32.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.853 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.91 128.95 41.56 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.064 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.426 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -77.33 116.33 17.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.784 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.46 9.14 29.68 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.649 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.91 -150.42 26.79 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.344 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -178.44 156.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.867 0.365 . . . . 0.0 110.988 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 64.05 27.9 14.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.0 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.8 p90 -59.54 -40.63 87.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.851 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.0 t -64.76 -25.69 68.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.034 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.67 -26.34 10.38 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.578 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.76 30.08 4.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.828 0.347 . . . . 0.0 110.814 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.773 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.51 161.44 28.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.094 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 99.5 p -131.51 150.7 52.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.068 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.24 64.04 0.76 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.684 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.857 HG22 HD11 ' A' ' 75' ' ' LEU . 11.0 mt -87.15 117.37 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -144.44 159.53 42.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.053 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.687 ' CD1' HD23 ' A' ' 93' ' ' LEU . 7.2 tp -105.15 128.52 53.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.942 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.45 153.98 46.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.996 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 71' ' ' ASN . 4.9 mm -84.88 138.81 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -141.98 137.86 31.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 96.34 166.14 33.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.443 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.96 -10.0 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.625 0.25 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.604 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.79 -3.39 45.77 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.429 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 63.22 79.31 0.26 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 121.002 0.43 . . . . 0.0 110.632 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.2 mm -111.18 120.62 42.66 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.144 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . 32.9 Cg_endo -64.1 102.56 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.5 2.133 . . . . 0.0 112.244 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 72' ' ' ILE . 32.9 t -108.37 128.78 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.299 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.857 HD11 HG22 ' A' ' 62' ' ' ILE . 56.0 tp -94.43 117.96 30.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.749 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 16.5 mtm180 -118.31 132.14 56.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.117 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.765 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 141.32 4.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.165 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -67.15 107.89 2.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.645 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.7 mt -92.04 150.05 21.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.139 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.19 109.09 59.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.649 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.84 167.58 26.89 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.359 2.039 . . . . 0.0 112.314 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 1.2 ptp -76.29 -23.16 54.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.968 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -76.65 -40.91 47.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 133.69 164.99 10.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.504 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 61.39 98.17 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.652 0.263 . . . . 0.0 110.932 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.67 153.31 19.25 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.533 2.156 . . . . 0.0 112.279 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.4 m -135.32 144.87 32.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.54 113.07 3.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.783 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.46 144.85 31.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.42 122.28 14.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.988 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.503 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -130.35 133.41 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.136 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -88.77 109.22 19.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.345 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.687 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.2 mm? -49.62 -38.93 33.93 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.041 0.448 . . . . 0.0 110.846 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.7 m -60.49 -13.45 13.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.25 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -59.68 -47.4 85.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.695 0.283 . . . . 0.0 111.349 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.501 ' C ' HD13 ' A' ' 107' ' ' LEU . 3.9 mmm180 -140.31 40.12 1.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.486 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.89 117.87 51.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.731 0.3 . . . . 0.0 110.518 179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.58 -177.36 16.82 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.87 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.95 104.11 5.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.796 0.331 . . . . 0.0 110.683 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -94.61 116.91 29.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.135 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 t 54.41 31.29 14.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.65 -16.58 59.8 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.561 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 m -86.48 145.03 26.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.781 0.324 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -73.8 128.12 34.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.879 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -132.38 172.26 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -122.39 138.57 54.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.662 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.501 HD13 ' C ' ' A' ' 96' ' ' ARG . 8.1 mp -67.96 103.77 1.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.207 -0.902 . . . . 0.0 111.075 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.83 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.98 60.92 4.85 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.594 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -60.54 -15.08 23.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.571 . . . . 0.0 111.052 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.56 -32.52 2.32 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 120.741 0.305 . . . . 0.0 111.435 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.478 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.83 -34.58 78.7 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.92 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.94 -23.84 41.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.17 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.1 m -109.38 17.63 21.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.278 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.708 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 42.1 t -130.65 160.54 33.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.81 0.338 . . . . 0.0 110.951 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.7 t30 -124.82 159.8 30.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.784 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.402 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 8.8 m-20 58.5 58.74 3.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.451 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.2 mm -93.27 117.03 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.751 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -161.36 -173.18 3.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.029 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.44 146.84 52.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.035 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 28.8 tt0 -119.92 118.74 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 61.24 17.54 8.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.29 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.476 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.5 56.33 24.97 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.791 -0.718 . . . . 0.0 113.117 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' CE1' HG12 ' A' ' 18' ' ' ILE . 6.9 p-80 -176.43 -32.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.626 0.25 . . . . 0.0 111.421 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.6 mm -101.33 135.0 39.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.907 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD12 HD13 ' A' ' 93' ' ' LEU . 10.0 tt -114.15 142.49 46.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.092 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.462 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -134.94 136.15 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.298 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.708 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.73 140.84 3.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.238 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -92.47 97.63 10.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.636 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.6 m -101.38 130.15 47.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.92 177.43 50.05 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.411 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.69 -29.04 7.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.728 0.299 . . . . 0.0 110.863 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 136.84 -28.38 2.84 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.462 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -64.68 -29.36 70.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.96 -4.81 5.71 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.863 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.11 164.12 12.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.841 0.353 . . . . 0.0 110.965 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -103.38 157.84 16.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.979 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 t -134.0 116.8 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.411 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -68.21 120.93 15.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.161 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.485 ' HB2' HD23 ' A' ' 104' ' ' LEU . 36.9 m -137.31 169.33 17.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.744 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -150.57 152.7 34.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 111.089 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.8 tp -133.9 142.41 47.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.935 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 34.5 t70 -97.23 121.84 39.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 110.335 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.937 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.84 20.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.666 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -57.65 -11.94 2.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.713 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -127.32 -0.54 6.34 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.556 179.734 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.86 -19.66 8.49 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.562 0.22 . . . . 0.0 111.28 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.873 HD12 ' HB3' ' A' ' 37' ' ' LEU . 21.6 mt -125.84 141.31 45.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.773 0.32 . . . . 0.0 110.965 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.85 179.27 16.92 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.596 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' ND2' HD22 ' A' ' 79' ' ' LEU . 61.3 t-20 -106.34 112.5 25.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.368 . . . . 0.0 110.861 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -111.72 98.13 7.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.7 t70 60.05 47.13 10.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 18.39 72.23 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.582 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 m -128.76 147.96 50.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.583 ' CD2' HG12 ' A' ' 91' ' ' VAL . 16.7 m-85 -66.84 141.31 57.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.854 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 124.74 31.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.102 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 27.7 m95 -75.06 120.37 20.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.788 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.42 12.35 41.94 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.767 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.37 -147.53 22.79 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.238 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 179.83 155.31 0.57 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 66.34 28.61 9.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.92 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 62' ' ' ILE . 19.4 p90 -61.82 -40.56 95.71 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.788 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 10.8 t -67.63 -25.92 65.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.008 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.18 -25.97 12.04 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.65 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.75 29.22 5.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.808 0.337 . . . . 0.0 110.809 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.612 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -126.35 164.49 20.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 93.1 p -134.6 150.3 50.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.211 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 37.39 63.75 0.71 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.766 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 9.5 mt -84.32 117.91 30.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.23 158.5 43.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.085 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 73' ' ' PRO . 9.1 tp -105.14 129.62 53.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.026 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.51 153.9 46.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.76 142.83 12.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.822 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' CB ' HG21 ' A' ' 74' ' ' VAL . 1.9 tm-20 -142.45 136.3 29.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.896 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.82 170.13 40.09 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.542 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -81.81 -12.91 58.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.593 0.235 . . . . 0.0 111.341 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 3.2 m-20 -89.29 -7.67 54.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.323 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.483 ' HA ' HG23 ' A' ' 66' ' ' ILE . 24.1 m-80 66.23 75.79 0.32 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.015 0.436 . . . . 0.0 110.663 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.722 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.3 mm -107.93 125.22 32.6 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.01 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.515 ' HB2' HD11 ' A' ' 64' ' ' LEU . 29.8 Cg_endo -63.1 102.58 0.32 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.529 2.152 . . . . 0.0 112.446 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.7 t -105.1 117.73 51.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.244 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 25.1 tp -88.99 118.15 28.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.724 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -118.25 134.8 54.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.13 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 149.1 7.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.16 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -75.97 108.87 9.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.693 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.754 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.6 mt -94.39 151.93 19.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.185 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -103.01 109.95 62.55 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.539 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -74.62 167.53 26.89 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.503 2.136 . . . . 0.0 112.428 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -77.84 -22.14 50.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.03 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.3 -45.73 45.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.811 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 144.03 154.43 6.13 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.578 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 63.81 118.44 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.548 0.213 . . . . 0.0 110.945 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.5 Cg_endo -69.89 147.59 62.39 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.398 2.065 . . . . 0.0 112.271 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 24.7 m -128.27 148.35 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 114.59 6.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.754 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.42 144.34 32.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.85 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.87 123.41 17.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.16 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.583 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.5 p -135.11 131.7 52.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.946 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.7 t30 -85.66 117.23 24.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.472 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.771 HD13 HD12 ' A' ' 19' ' ' LEU . 43.4 mt -55.24 -37.83 67.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.121 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.436 ' O ' ' N ' ' A' ' 2' ' ' GLY . 2.2 m -60.24 -13.59 13.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.447 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -59.62 -46.96 87.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.715 0.293 . . . . 0.0 111.304 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HA ' HD22 ' A' ' 107' ' ' LEU . 4.7 mmm180 -141.08 40.53 1.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.509 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.93 117.75 51.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 110.554 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.94 -175.9 15.81 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.712 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -135.38 106.49 6.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.811 0.339 . . . . 0.0 110.802 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -96.48 116.78 29.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.8 t 55.18 30.92 15.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.047 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.87 -15.77 60.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.71 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.9 m -86.54 145.28 26.84 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.825 0.345 . . . . 0.0 110.906 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.3 mm? -72.91 128.7 36.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.755 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.1 pt -135.28 174.27 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.201 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.443 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.35 138.59 54.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.658 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.7 mp -67.9 98.35 0.73 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.882 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.443 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.082 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' N ' HD21 ' A' ' 107' ' ' LEU . 7.9 mtm . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.797 0.332 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -77.81 63.61 3.44 Favored Glycine 0 CA--C 1.509 -0.337 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.352 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.4 p30 -63.36 -14.95 55.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.05 -0.575 . . . . 0.0 110.918 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.39 -32.99 2.33 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.705 0.288 . . . . 0.0 111.414 -178.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.648 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -65.07 -38.47 90.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.92 0.39 . . . . 0.0 110.672 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.61 -25.34 53.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.14 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -105.75 16.65 24.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.295 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.635 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 35.6 t -133.78 154.75 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.828 0.347 . . . . 0.0 110.973 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -122.83 157.86 31.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.636 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 60.92 56.87 2.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -92.74 116.78 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.651 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.3 p-90 -156.93 -173.69 4.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.944 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 37' ' ' LEU . 10.1 tp -132.46 146.49 51.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.072 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 37.8 tt0 -116.63 122.92 45.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.88 17.46 6.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.217 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.684 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.09 54.71 34.46 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.097 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.554 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -175.42 -33.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.61 0.205 . . . . 0.0 111.423 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.6 mm -100.77 127.21 54.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.857 0.361 . . . . 0.0 111.001 179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD12 HD13 ' A' ' 93' ' ' LEU . 8.3 tt -107.65 142.87 36.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.033 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -136.31 134.43 37.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.4 179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.635 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -166.06 141.81 4.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.209 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.27 97.86 10.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.68 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.7 m -99.09 137.15 38.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.009 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.25 173.84 55.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.424 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -28.4 7.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.709 0.29 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.28 -24.72 4.97 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.426 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -67.88 -27.57 66.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.893 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.49 -3.52 5.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.838 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.13 162.86 14.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.803 0.335 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -107.1 154.27 21.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.947 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 t -129.58 129.98 66.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.229 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -83.28 118.38 23.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.644 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.751 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.8 m -133.52 169.32 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.3 p -144.13 155.43 43.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.094 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.41 134.49 39.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.85 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 26.8 t0 -94.82 123.12 38.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.946 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.47 -29.73 19.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.582 179.471 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -56.8 -12.87 2.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.698 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.21 -0.26 6.42 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.645 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-30 -118.2 -22.68 7.63 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.648 0.261 . . . . 0.0 111.235 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.817 HD12 ' HB3' ' A' ' 37' ' ' LEU . 14.4 mt -124.53 141.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.856 0.36 . . . . 0.0 110.969 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.97 177.23 18.0 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.574 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.477 HD22 HD22 ' A' ' 79' ' ' LEU . 21.8 t-20 -95.87 108.54 20.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -111.84 97.91 7.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.1 t0 56.28 47.36 19.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.73 70.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 17.5 m -128.7 163.81 24.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 110.839 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.4 m-85 -82.56 139.54 33.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.65 128.3 40.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CH2' HG12 ' A' ' 97' ' ' ILE . 41.5 m95 -76.87 116.9 17.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.82 8.75 31.64 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.725 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.35 -152.29 29.16 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.418 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -177.8 157.91 1.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.88 0.372 . . . . 0.0 110.982 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.68 27.23 11.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.692 ' HE2' HG21 ' A' ' 62' ' ' ILE . 17.7 p90 -60.77 -42.85 98.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.806 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HA ' HD11 ' A' ' 62' ' ' ILE . 21.2 t -63.25 -27.51 69.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.93 -25.92 25.06 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.694 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -126.83 28.81 5.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.746 0.308 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.783 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -129.04 170.76 13.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.107 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.4 m -140.59 150.39 43.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.63 63.66 0.97 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.614 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.85 HG22 HD11 ' A' ' 75' ' ' LEU . 8.3 mt -87.56 118.63 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.944 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.744 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.04 159.0 43.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.084 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.662 HD21 ' HB2' ' A' ' 73' ' ' PRO . 14.7 tp -105.18 131.62 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.97 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -128.49 153.93 46.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.022 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.0 mm -84.98 141.27 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.705 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -148.62 132.83 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.12 151.84 26.1 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.511 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -62.09 -22.28 65.66 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.746 0.307 . . . . 0.0 111.417 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -86.63 -3.42 59.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.453 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.405 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.7 m-80 65.39 75.54 0.35 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.059 0.457 . . . . 0.0 110.672 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.648 HD13 ' CE1' ' A' ' 5' ' ' HIS . 3.5 mm -103.36 126.3 32.57 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.071 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.662 ' HB2' HD21 ' A' ' 64' ' ' LEU . 60.7 Cg_endo -72.67 101.93 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.517 2.145 . . . . 0.0 112.351 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.46 119.64 53.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.236 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.85 HD11 HG22 ' A' ' 62' ' ' ILE . 33.4 tp -85.11 118.04 24.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.731 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -117.79 132.14 56.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.046 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.722 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.08 144.68 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.136 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -70.46 112.22 6.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.744 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD23 ' HB2' ' A' ' 59' ' ' ALA . 43.6 mt -99.38 151.12 21.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.067 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -100.74 108.46 53.84 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.679 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.5 Cg_endo -75.68 167.54 26.19 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.546 2.164 . . . . 0.0 112.474 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.59 -21.03 45.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -73.26 -42.66 62.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.845 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 140.11 149.47 5.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.5 t70 65.97 122.61 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.513 0.196 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 55.2 Cg_endo -69.87 143.74 51.27 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.402 2.068 . . . . 0.0 112.19 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.71 142.7 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.074 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.56 114.31 4.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.715 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 145.65 30.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.51 122.32 16.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.92 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' CD2' ' A' ' 48' ' ' PHE . 15.0 p -128.94 137.31 57.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.457 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.4 t30 -92.12 107.64 19.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.498 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 HD12 ' A' ' 19' ' ' LEU . 39.2 mt -49.48 -38.84 31.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.101 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.7 p -59.63 -13.56 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.412 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -61.21 -46.71 89.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.705 0.288 . . . . 0.0 111.316 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.515 ' HA ' HD22 ' A' ' 107' ' ' LEU . 5.3 mmm180 -140.04 38.76 1.95 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.521 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 31.4 mm -125.07 117.83 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.729 0.299 . . . . 0.0 110.636 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.74 -176.6 16.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.847 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -135.07 103.95 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.699 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -93.37 116.86 29.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.987 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 54.03 31.26 13.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.035 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.45 -16.09 60.76 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.661 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.5 m -86.49 144.85 27.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.751 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.94 128.41 35.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.88 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -132.5 174.47 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.78 138.7 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.657 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.0 mp -67.83 104.46 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.816 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.098 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptt? . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.484 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -91.73 62.13 2.68 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.599 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.02 -15.05 41.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.118 -0.541 . . . . 0.0 110.911 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.1 p90 -45.36 -33.45 2.53 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 111.324 -178.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.633 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.25 -38.27 88.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.918 0.389 . . . . 0.0 110.687 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.0 -24.54 47.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.187 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -107.68 16.33 23.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.295 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.552 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 28.6 t -131.39 156.47 45.5 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.864 0.364 . . . . 0.0 110.978 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -122.09 159.8 26.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.621 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 25.3 m-20 60.2 60.27 2.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.601 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -94.45 116.68 36.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.487 179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.546 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.5 p-90 -159.5 -174.09 4.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.03 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 37' ' ' LEU . 9.1 tp -131.01 148.08 52.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.995 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 29.4 tt0 -120.53 118.05 29.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.692 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 62.49 16.0 8.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.224 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.538 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 61.98 55.62 27.14 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.138 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.475 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.7 p-80 -175.91 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.596 0.236 . . . . 0.0 111.429 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 17' ' ' HIS . 21.5 mm -98.07 131.44 45.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 110.973 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.724 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.05 139.48 46.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.724 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.08 134.18 38.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.335 179.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.552 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.81 141.9 8.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.263 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -94.83 97.78 10.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.663 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 11.8 m -101.76 141.35 34.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.02 179.52 53.19 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.498 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 -36.57 4.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.799 0.333 . . . . 0.0 110.816 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.36 -28.3 1.09 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.273 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -65.95 -30.36 70.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.918 0.39 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.99 -6.03 6.08 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.635 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -100.38 166.12 11.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.946 0.403 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.7 m-30 -105.51 155.95 18.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.974 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.9 t -134.82 114.54 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.278 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.54 123.06 17.35 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.266 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.812 ' HB2' HD23 ' A' ' 104' ' ' LEU . 20.2 m -138.17 168.85 18.86 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.411 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 67.5 p -145.51 156.99 44.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.986 0.422 . . . . 0.0 111.331 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -139.17 136.2 34.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.699 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 35.8 t70 -95.15 121.95 37.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.045 0.45 . . . . 0.0 110.638 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.885 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -29.1 20.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.631 179.808 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -57.11 -12.84 2.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.587 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.78 2.51 6.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.557 179.816 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -119.04 -26.39 5.98 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.611 0.243 . . . . 0.0 111.232 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.717 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.9 mt -121.93 143.92 32.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.919 0.39 . . . . 0.0 111.143 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.03 174.52 19.51 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.327 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.468 ' CG ' HD22 ' A' ' 79' ' ' LEU . 61.8 t-20 -98.77 111.08 23.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.853 0.359 . . . . 0.0 110.97 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -111.82 98.1 7.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.8 t70 59.7 48.23 9.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.883 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.28 17.76 70.61 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.587 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.05 162.23 27.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD1' HD11 ' A' ' 79' ' ' LEU . 19.6 m-85 -81.99 140.36 34.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 p -130.57 128.31 40.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.079 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.8 m95 -76.23 118.0 18.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.75 8.54 34.5 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.23 -149.76 25.93 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.408 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.93 156.82 0.84 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.919 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 64.77 27.64 12.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.967 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.663 ' HE2' HG21 ' A' ' 62' ' ' ILE . 28.5 p90 -57.92 -40.26 79.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.83 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 11.2 t -69.47 -23.16 63.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.089 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.8 -26.02 10.28 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.737 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.0 30.33 4.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.754 0.311 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -124.85 172.33 9.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.113 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 m -142.36 150.42 40.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.57 65.31 0.72 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.599 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.962 HG22 HD11 ' A' ' 75' ' ' LEU . 3.9 mt -90.56 121.61 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.686 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -145.88 155.92 43.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.087 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.646 HD21 ' HB2' ' A' ' 73' ' ' PRO . 5.3 tp -105.11 127.85 53.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.932 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.59 153.94 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.97 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.543 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.3 mm -84.81 145.04 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.676 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.14 136.93 24.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 94.31 169.9 37.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.551 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -78.29 -19.19 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 111.212 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.7 OUTLIER -85.16 -8.29 58.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.365 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.543 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.5 m-80 66.58 73.72 0.35 Allowed 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.075 0.464 . . . . 0.0 110.651 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.633 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.4 mm -102.65 113.89 65.64 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.097 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.646 ' HB2' HD21 ' A' ' 64' ' ' LEU . 30.3 Cg_endo -63.74 102.65 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.42 2.08 . . . . 0.0 112.192 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 72' ' ' ILE . 35.5 t -106.59 128.31 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.251 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.962 HD11 HG22 ' A' ' 62' ' ' ILE . 24.3 tp -91.03 116.91 29.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.616 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 mtm180 -115.61 133.04 56.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.702 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.02 150.84 8.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.146 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -77.33 111.43 12.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.769 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.762 HD12 ' CB ' ' A' ' 89' ' ' ALA . 32.6 mt -98.39 149.02 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -98.65 109.14 52.0 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.585 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 67.3 Cg_endo -74.11 167.58 26.86 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.535 2.156 . . . . 0.0 112.467 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -74.99 -24.26 58.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.932 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -74.51 -42.7 58.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.87 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.17 159.71 8.35 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.479 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.3 108.51 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.529 0.204 . . . . 0.0 110.779 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.401 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 37.7 Cg_endo -66.32 143.96 72.39 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.363 2.042 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.13 148.28 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.58 114.01 4.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.816 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.762 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 145.03 31.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.799 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.6 129.46 28.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.045 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.9 p -134.98 131.32 52.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.008 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.565 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.5 t30 -87.42 106.99 18.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.414 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 71.0 mt -49.14 -37.96 23.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.966 0.412 . . . . 0.0 110.879 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.8 m -59.88 -13.66 11.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.394 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.1 -46.1 90.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.67 0.271 . . . . 0.0 111.284 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.52 38.99 1.87 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.668 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.484 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.1 mm -124.91 117.93 51.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.726 0.298 . . . . 0.0 110.459 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.21 -176.39 16.89 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.925 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -134.7 103.19 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.782 0.325 . . . . 0.0 110.726 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.51 116.79 29.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.948 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.8 t 55.24 30.55 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.4 -16.44 59.89 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.611 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.3 m -86.53 145.99 26.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.812 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.95 128.78 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.937 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -134.7 171.55 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.032 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -122.47 138.53 54.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.64 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.425 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.0 mm? -67.92 100.96 1.02 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.101 -179.954 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mtt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.789 0.328 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.482 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -90.37 61.14 3.26 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.355 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -59.58 -15.39 18.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.894 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.81 -32.32 2.51 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.703 0.287 . . . . 0.0 111.397 -178.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.596 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.4 p80 -64.52 -36.96 85.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.922 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.96 -24.28 48.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.226 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.2 t -108.24 18.39 21.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.328 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 32.4 t -132.63 154.79 49.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 111.086 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -120.07 159.8 24.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.522 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 59.01 57.23 3.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.746 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.466 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.8 mm -92.38 118.85 38.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.976 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.664 ' HA ' HD23 ' A' ' 64' ' ' LEU . 11.8 p-90 -162.85 -175.68 4.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.855 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.7 HD11 HD11 ' A' ' 37' ' ' LEU . 8.9 tp -134.27 148.44 50.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 55.2 tt0 -117.93 121.31 40.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.718 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 59.35 18.83 7.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.216 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 58.35 56.65 24.09 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.944 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.501 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.2 p-80 -176.06 -31.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.613 0.244 . . . . 0.0 111.264 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 HG12 ' CD2' ' A' ' 17' ' ' HIS . 21.8 mm -104.15 116.95 48.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 110.821 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.933 HD12 HD13 ' A' ' 93' ' ' LEU . 9.6 tt -100.25 142.07 32.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.11 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.451 ' ND1' ' CE2' ' A' ' 12' ' ' TRP . 0.0 OUTLIER -136.35 133.09 36.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.178 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.07 144.64 8.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.278 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -95.61 97.82 10.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 25.7 m -99.75 138.14 37.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.938 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.06 177.6 53.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.449 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.08 -29.26 7.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 110.944 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 131.12 -25.25 4.13 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.449 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -69.12 -28.19 66.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.337 . . . . 0.0 110.993 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.83 -5.6 5.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.867 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -105.92 156.23 18.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.367 . . . . 0.0 110.822 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -102.83 153.17 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -130.16 129.6 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -84.6 117.76 23.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.638 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.479 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -131.35 169.36 16.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.827 179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 20' ' ' HIS . 73.8 p -144.6 155.37 43.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.073 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.8 134.17 31.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.879 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 2.2 t0 -94.39 124.69 38.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.654 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.871 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.42 -27.72 21.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.656 179.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -57.45 -11.34 1.86 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.783 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.6 0.44 5.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.664 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.1 m-85 -121.29 -12.76 8.59 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.576 0.227 . . . . 0.0 111.412 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.871 HD12 ' HB3' ' A' ' 37' ' ' LEU . 30.6 mt -133.22 139.48 49.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 120.796 0.331 . . . . 0.0 110.915 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.14 176.83 17.96 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.684 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.549 ' CG ' HD22 ' A' ' 79' ' ' LEU . 60.4 t-20 -99.91 110.99 23.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.377 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -112.0 98.65 7.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t70 59.62 46.53 11.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.936 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.95 18.31 72.52 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.656 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.6 t -128.09 163.2 25.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.838 0.352 . . . . 0.0 110.868 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD2' HG12 ' A' ' 91' ' ' VAL . 19.0 m-85 -82.53 139.6 33.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.93 126.4 36.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.095 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -74.78 118.38 17.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.8 8.33 34.72 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.748 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.13 -150.63 27.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.257 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -178.07 157.62 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.016 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 64.05 28.87 14.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.908 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.65 ' HE2' HG21 ' A' ' 62' ' ' ILE . 23.6 p90 -60.78 -37.57 82.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.749 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 24.6 t -69.37 -25.13 64.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.081 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.44 -29.32 23.36 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.496 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -126.45 27.8 6.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.856 0.36 . . . . 0.0 110.766 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -122.42 166.93 13.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.103 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 m -138.86 150.8 46.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.819 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.43 66.51 0.56 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.632 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.049 HG22 HD11 ' A' ' 75' ' ' LEU . 2.9 mt -90.67 124.02 43.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -147.68 159.96 43.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.95 0.405 . . . . 0.0 111.347 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 12' ' ' TRP . 59.3 tp -104.94 128.94 53.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -128.6 153.09 47.6 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.192 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.1 mm -91.35 134.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.519 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.34 140.87 39.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.952 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.48 158.72 34.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -69.97 -12.03 61.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.612 0.244 . . . . 0.0 111.31 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.427 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.0 OUTLIER -92.27 -9.73 41.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.317 -179.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.627 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.9 m-80 67.94 76.8 0.26 Allowed 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 121.018 0.437 . . . . 0.0 110.559 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.596 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.5 mm -105.97 113.97 63.15 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.474 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.593 ' C ' HD11 ' A' ' 64' ' ' LEU . 25.1 Cg_endo -61.97 102.85 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.577 2.184 . . . . 0.0 112.192 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.519 ' HA ' ' HA ' ' A' ' 92' ' ' ASN . 3.4 p -111.48 125.43 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.415 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.049 HD11 HG22 ' A' ' 62' ' ' ILE . 24.6 tp -88.84 138.18 31.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.848 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.415 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 31.0 mtm180 -129.11 136.81 50.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.986 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.02 141.23 4.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.353 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -74.34 105.45 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.142 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.763 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.6 mt -91.88 147.16 23.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.042 0.448 . . . . 0.0 111.478 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -95.37 106.41 26.17 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.53 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 71.9 Cg_endo -75.7 167.43 26.4 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.404 2.069 . . . . 0.0 112.404 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -77.73 -22.55 50.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.89 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.78 -46.8 57.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.868 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 137.75 152.25 6.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.523 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 t0 67.49 102.95 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.581 0.229 . . . . 0.0 110.908 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 64.5 Cg_exo -51.14 148.67 17.42 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.482 2.121 . . . . 0.0 112.297 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.1 p -129.64 142.0 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.06 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.6 113.25 4.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.763 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 143.11 34.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.008 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.415 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -141.14 122.3 14.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.93 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -128.94 137.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.112 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.57 ' OD1' HG22 ' A' ' 72' ' ' ILE . 1.3 t30 -91.64 110.22 21.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.474 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.933 HD13 HD12 ' A' ' 19' ' ' LEU . 57.8 mt -49.67 -38.29 32.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.021 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.414 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 3.7 m -60.04 -13.77 13.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.318 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -47.38 85.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.693 0.282 . . . . 0.0 111.234 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.25 40.91 1.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.503 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.482 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 27.0 mm -124.7 117.82 51.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.733 0.301 . . . . 0.0 110.466 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.6 -174.56 16.81 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.745 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -134.68 102.73 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.773 0.321 . . . . 0.0 110.763 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -91.69 116.82 29.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 18.9 t 53.74 30.18 10.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.72 -15.42 62.63 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.611 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 32.3 m -86.59 147.26 26.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.829 0.347 . . . . 0.0 110.845 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.96 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.3 pt -134.83 175.41 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.12 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -124.4 138.63 54.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.653 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.7 mp -67.93 106.37 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.118 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtm . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.817 0.342 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.491 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.45 60.89 3.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.682 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -60.92 -15.04 26.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.117 -0.542 . . . . 0.0 111.032 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.63 -32.61 2.45 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-O 120.733 0.301 . . . . 0.0 111.481 -178.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.486 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.2 p80 -64.81 -35.21 80.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.909 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 -21.25 45.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.269 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.9 m -112.91 19.21 17.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.274 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.625 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 36.9 t -132.67 154.66 49.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.887 0.375 . . . . 0.0 111.016 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -119.15 159.8 23.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.688 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 60.96 56.94 2.7 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.895 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.447 HD11 ' C ' ' A' ' 8' ' ' SER . 1.2 mm -94.1 117.14 37.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.723 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.8 p-90 -161.47 -175.06 4.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 37' ' ' LEU . 8.3 tp -130.97 142.09 50.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 62.9 tt0 -117.17 124.46 49.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.03 17.43 7.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.03 51.33 59.85 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.103 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.501 ' CE1' HG12 ' A' ' 18' ' ' ILE . 21.7 p-80 -174.48 -27.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 13' ' ' LEU . 21.2 mm -101.77 135.24 39.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.873 0.368 . . . . 0.0 111.067 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.609 HD12 HD13 ' A' ' 93' ' ' LEU . 9.9 tt -113.45 142.01 46.41 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.209 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.482 ' N ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -139.62 133.05 30.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.308 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.625 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -160.87 150.11 16.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.282 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -101.46 97.82 8.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.68 129.5 47.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.965 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.38 175.97 50.66 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.409 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.55 -29.46 6.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 0.0 110.959 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 130.43 -25.63 4.24 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.421 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -65.21 -26.82 68.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.58 -0.33 6.83 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.859 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.99 163.52 15.47 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.789 0.328 . . . . 0.0 110.882 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -104.4 152.4 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.67 130.41 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.136 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -85.89 121.27 28.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.669 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -137.01 169.32 17.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 20' ' ' HIS . 46.8 p -147.03 157.66 43.69 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.012 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.57 135.85 32.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.4 t70 -94.37 123.76 37.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.825 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.964 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.36 -29.16 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -57.89 -12.03 2.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.731 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.513 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -127.62 -0.7 6.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.567 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -117.72 -22.04 8.2 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-O 120.642 0.258 . . . . 0.0 111.081 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.814 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.9 mt -124.4 140.84 46.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.834 0.35 . . . . 0.0 110.882 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.77 176.62 18.24 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.625 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 79' ' ' LEU . 59.9 t-20 -99.85 111.86 24.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -111.67 98.18 7.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 60.78 45.23 10.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.97 17.7 75.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.592 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 m -128.77 160.37 32.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.83 0.348 . . . . 0.0 110.834 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' HG12 ' A' ' 91' ' ' VAL . 27.2 m-85 -75.79 141.78 42.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.889 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.03 124.47 30.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.048 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.429 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.7 m95 -75.53 118.99 18.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.718 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.64 11.86 36.87 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.708 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -98.37 -147.44 22.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.319 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -179.47 158.63 0.85 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 111.091 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.82 27.92 10.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.022 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.603 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.7 p90 -60.49 -40.54 91.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.908 0.385 . . . . 0.0 110.756 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.59 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 31.2 t -67.51 -17.88 64.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.986 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -48.2 -40.73 22.12 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.509 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.538 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -124.29 35.02 4.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.786 0.327 . . . . 0.0 110.832 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.43 160.85 22.27 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.895 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.2 m -135.06 150.79 50.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.976 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.58 61.78 1.32 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.674 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.84 HG22 HD11 ' A' ' 75' ' ' LEU . 9.8 mt -84.1 114.53 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.72 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.761 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.65 156.33 46.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 0.0 111.277 -179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD11 ' HB2' ' A' ' 73' ' ' PRO . 32.1 tp -105.12 126.62 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.78 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -127.03 153.95 45.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.008 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.603 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.87 142.9 12.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.724 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -147.49 133.42 19.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.863 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.65 157.21 29.52 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.466 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -67.79 -14.22 62.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.609 0.242 . . . . 0.0 111.298 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.59 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -92.22 -11.71 34.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.325 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.603 ' HA ' HG23 ' A' ' 66' ' ' ILE . 18.9 m-80 70.03 76.45 0.21 Allowed 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.002 0.43 . . . . 0.0 110.574 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.777 HG22 ' OD1' ' A' ' 92' ' ' ASN . 1.7 mm -105.55 123.81 38.28 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HB2' HD11 ' A' ' 64' ' ' LEU . 27.9 Cg_endo -62.68 102.78 0.3 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.531 2.154 . . . . 0.0 112.488 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -105.69 119.12 54.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.324 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.84 HD11 HG22 ' A' ' 62' ' ' ILE . 27.9 tp -91.92 120.97 33.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.668 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.8 mtm180 -120.77 133.09 55.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.323 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 141.21 4.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.01 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 28.6 mt-10 -70.33 113.62 7.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.723 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD12 ' CB ' ' A' ' 89' ' ' ALA . 27.7 mt -99.89 149.59 23.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.509 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 20.7 m-80 -95.14 107.19 30.41 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.599 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.413 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.3 Cg_endo -74.73 164.6 33.3 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.343 2.028 . . . . 0.0 112.319 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.1 ptp -77.92 -19.73 54.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.164 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -76.7 -38.36 54.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 110.886 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.66 153.96 6.82 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.0 t0 63.06 121.21 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.508 0.194 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.413 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 44.4 Cg_endo -68.04 148.1 75.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.425 2.083 . . . . 0.0 112.217 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 29.1 m -129.7 143.83 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.13 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -65.52 113.6 4.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.762 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.779 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.4 141.17 37.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.942 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -137.43 122.36 18.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.986 -179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.515 HG12 ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -132.08 134.77 59.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.078 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' A' ' 72' ' ' ILE . 4.1 t30 -91.12 114.59 27.15 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.383 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.609 HD13 HD12 ' A' ' 19' ' ' LEU . 42.8 mt -51.95 -38.23 55.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.112 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 2' ' ' GLY . 1.9 m -60.57 -13.52 14.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.396 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.91 -47.26 85.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.276 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -141.35 40.85 1.76 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.531 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.491 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.5 mm -124.84 117.83 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.704 0.288 . . . . 0.0 110.47 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.6 -176.0 16.0 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.847 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -136.7 105.65 5.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 0.0 110.732 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.88 116.94 29.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 11.1 t 56.2 30.63 16.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.042 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.36 -15.38 61.41 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.72 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.9 m -86.7 145.19 26.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.765 0.317 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 129.8 38.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.9 pt -135.24 174.8 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -124.79 138.53 54.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.614 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.98 101.85 1.19 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.1 -179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.441 ' H3 ' HD21 ' A' ' 107' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -79.43 62.2 4.11 Favored Glycine 0 CA--C 1.509 -0.327 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.294 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -61.86 -14.95 38.39 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.056 -0.572 . . . . 0.0 111.048 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' HB3' ' HA2' ' A' ' 98' ' ' GLY . 1.0 OUTLIER -45.44 -33.15 2.47 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.745 0.307 . . . . 0.0 111.379 -178.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.561 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.41 -36.85 85.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.952 0.406 . . . . 0.0 110.738 179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.48 -25.39 50.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.122 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 p -106.38 17.42 23.42 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.236 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.692 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 29.6 t -134.2 154.93 50.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.868 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -122.76 159.49 27.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.656 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 61.14 55.92 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.726 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.1 mm -92.62 116.86 34.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.56 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.717 ' HA ' HD23 ' A' ' 64' ' ' LEU . 10.7 p-90 -157.09 -172.96 4.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.045 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 37' ' ' LEU . 8.1 tp -134.16 143.87 48.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.003 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 33.4 tt0 -114.14 121.42 43.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.772 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.58 18.27 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.199 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.46 56.27 26.0 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.045 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.8 p-80 -175.7 -31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.628 0.251 . . . . 0.0 111.478 179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.5 mm -102.4 131.67 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.906 0.384 . . . . 0.0 110.839 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.682 HD12 HD13 ' A' ' 93' ' ' LEU . 10.2 tt -111.31 141.49 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.978 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.523 ' HA ' HG22 ' A' ' 34' ' ' THR . 0.0 OUTLIER -137.85 133.25 33.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.414 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.692 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -164.44 150.09 10.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.224 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.73 99.64 9.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.622 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 15.2 m -99.33 137.55 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.085 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -80.15 173.0 54.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.499 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -26.32 8.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.724 0.297 . . . . 0.0 111.029 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.5 -27.02 4.52 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.414 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -63.38 -28.39 69.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.951 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.13 -2.35 5.87 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.891 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -115.53 162.73 16.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.799 0.333 . . . . 0.0 110.779 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.408 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 3.1 m-85 -104.68 155.29 18.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.6 t -129.29 129.05 67.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.611 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -73.34 131.76 42.27 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.844 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.718 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -149.7 158.07 43.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.911 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.523 HG22 ' HA ' ' A' ' 20' ' ' HIS . 45.6 p -140.97 151.81 44.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.03 138.77 45.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 23.6 t0 -96.83 123.43 40.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.725 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.991 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.44 -28.68 20.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.707 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.24 -12.43 2.34 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.671 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.88 1.65 5.36 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.711 179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.503 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m-30 -118.14 -25.99 6.49 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.662 0.267 . . . . 0.0 111.082 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.777 HD12 ' HB3' ' A' ' 37' ' ' LEU . 11.8 mt -122.12 142.93 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.89 0.376 . . . . 0.0 111.076 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.93 174.88 19.0 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.53 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' CG ' HD22 ' A' ' 79' ' ' LEU . 58.5 t-20 -99.32 111.48 23.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.861 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.82 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.792 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 60.39 46.15 10.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.731 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.62 18.3 73.73 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.586 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.75 159.26 36.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.812 0.339 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.9 m-85 -75.12 141.22 43.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 p -130.91 125.19 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.011 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.423 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.1 m95 -75.61 119.55 19.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.793 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.95 11.76 39.01 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.723 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.33 -148.57 24.2 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.235 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -179.12 155.99 0.76 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.927 0.394 . . . . 0.0 111.034 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 66.06 28.85 10.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.989 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.55 ' HE2' HG21 ' A' ' 62' ' ' ILE . 22.9 p90 -58.97 -39.75 82.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.811 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 32.9 t -66.52 -24.64 66.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.016 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.66 -27.62 13.21 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.611 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.79 25.26 6.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.791 0.329 . . . . 0.0 110.894 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.715 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.15 158.91 36.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.016 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.7 m -133.89 152.98 52.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.935 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.81 61.69 1.39 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.61 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.967 HG22 HD11 ' A' ' 75' ' ' LEU . 5.3 mt -87.06 123.33 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.752 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.698 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.2 158.85 43.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.898 0.38 . . . . 0.0 111.228 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.717 HD23 ' HA ' ' A' ' 12' ' ' TRP . 45.5 tp -106.5 128.91 54.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -128.53 153.84 46.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.964 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.425 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.03 145.14 8.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.828 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -147.51 133.85 19.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.96 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.11 155.33 31.75 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.587 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.2 -14.82 63.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.646 0.26 . . . . 0.0 111.276 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' HD11 ' A' ' 72' ' ' ILE . 3.4 m-20 -86.58 -10.23 54.4 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.352 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.425 ' HA ' HG23 ' A' ' 66' ' ' ILE . 19.6 m-80 66.33 73.46 0.37 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.034 0.445 . . . . 0.0 110.686 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.589 HG22 ' OD1' ' A' ' 92' ' ' ASN . 2.5 mm -105.44 117.77 57.34 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.032 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.529 ' C ' HD11 ' A' ' 64' ' ' LEU . 28.3 Cg_endo -62.75 102.33 0.29 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.511 2.141 . . . . 0.0 112.341 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 72' ' ' ILE . 33.3 t -106.26 117.66 52.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.198 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.967 HD11 HG22 ' A' ' 62' ' ' ILE . 29.0 tp -84.15 118.14 23.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.659 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 -116.2 132.75 56.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.122 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.77 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.04 150.44 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.208 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.64 108.34 13.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.689 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.752 HD12 ' CB ' ' A' ' 89' ' ' ALA . 28.3 mt -93.69 152.01 19.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.271 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -99.54 107.14 43.97 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.456 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.94 166.82 28.43 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.411 2.074 . . . . 0.0 112.419 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.3 ptm -77.62 -22.04 51.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -77.32 -30.65 54.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.868 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 120.83 162.73 11.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 t0 62.87 98.97 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -52.46 150.32 21.16 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.547 2.165 . . . . 0.0 112.286 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.7 m -134.58 142.14 41.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.116 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 116.91 7.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.752 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -107.9 143.22 36.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.984 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.27 122.21 17.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.892 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -129.04 135.1 62.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.201 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -90.39 108.15 19.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.408 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 19' ' ' LEU . 58.3 mt -49.08 -38.5 24.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.958 0.409 . . . . 0.0 111.05 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 2' ' ' GLY . 3.3 m -60.02 -13.65 12.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.335 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.47 -47.08 87.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.759 0.314 . . . . 0.0 111.309 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.74 39.79 1.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.48 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.48 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 30.3 mm -124.87 117.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.742 0.306 . . . . 0.0 110.433 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.8 -175.0 16.2 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -134.41 106.12 6.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.797 0.332 . . . . 0.0 110.727 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -96.09 116.87 29.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.972 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 3.5 t 56.17 30.0 15.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.001 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.59 -15.59 61.12 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.648 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.9 m -87.23 151.42 23.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.801 0.334 . . . . 0.0 110.873 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.718 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -75.92 130.6 38.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.963 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -136.39 169.36 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.219 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -121.83 138.53 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.633 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.441 HD21 ' H3 ' ' A' ' 1' ' ' MET . 2.7 mp -68.01 105.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.1 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.556 ' N ' HD21 ' A' ' 107' ' ' LEU . 2.1 ttt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.705 0.288 . . . . 0.0 111.248 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.19 56.01 4.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.337 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -59.62 -14.95 15.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.016 178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.478 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.48 -33.2 2.55 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 111.334 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.642 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.3 p80 -62.75 -37.45 86.65 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.88 0.371 . . . . 0.0 110.623 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.438 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 0.7 OUTLIER -79.44 -22.56 44.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.154 -179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.6 m -109.34 14.64 23.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.392 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.542 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.1 t -128.64 159.17 36.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.813 0.34 . . . . 0.0 111.003 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.85 159.75 27.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.55 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.8 m-20 59.05 59.74 2.66 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 mm -94.89 116.89 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.51 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.6 p-90 -160.89 -173.36 3.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.067 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 37' ' ' LEU . 7.0 tp -132.22 144.35 50.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 66.2 tt0 -118.7 121.8 40.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.691 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.439 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 61.47 17.69 8.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.123 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.48 53.12 48.76 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.124 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.505 ' CE1' HG12 ' A' ' 18' ' ' ILE . 14.8 p-80 -175.28 -27.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 17' ' ' HIS . 25.9 mm -104.43 133.42 48.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.885 0.374 . . . . 0.0 111.091 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD13 ' A' ' 93' ' ' LEU . 8.8 tt -112.12 142.37 44.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.037 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.439 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.51 135.77 37.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.239 179.596 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.542 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.83 152.67 9.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.371 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -105.28 99.14 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.671 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.9 m -102.8 134.78 45.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.108 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 178.01 49.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.416 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -111.31 -29.44 7.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.739 0.304 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.61 -28.24 2.67 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.432 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 -30.31 68.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.829 0.347 . . . . 0.0 110.859 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 133.94 -9.31 4.84 Favored Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.785 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -96.66 161.06 14.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.04 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -104.19 157.87 16.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.84 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.9 t -138.61 115.94 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.394 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -65.03 127.87 33.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.984 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.85 ' HB2' HD23 ' A' ' 104' ' ' LEU . 1.2 m -142.56 160.16 40.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.684 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 20' ' ' HIS . 80.7 p -142.49 146.82 35.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.072 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.534 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -130.09 140.93 50.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.813 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 41.4 t0 -97.56 123.71 41.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.045 0.45 . . . . 0.0 110.827 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.03 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.51 -28.46 20.79 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.701 179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -57.05 -12.8 2.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.32 3.31 5.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.493 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CD2' HD21 ' A' ' 35' ' ' LEU . 1.0 OUTLIER -118.64 -26.99 5.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.676 0.274 . . . . 0.0 111.068 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.828 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.7 mt -121.44 141.46 41.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.826 0.346 . . . . 0.0 110.994 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.82 177.57 17.76 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.598 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -95.14 109.32 21.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -111.85 98.02 7.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.36 47.49 18.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.29 16.89 71.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.56 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.3 t -128.81 163.66 24.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.791 0.329 . . . . 0.0 110.875 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CD1' HD11 ' A' ' 79' ' ' LEU . 24.7 m-85 -79.94 141.35 36.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.99 127.49 38.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CH2' HG12 ' A' ' 97' ' ' ILE . 39.3 m95 -76.42 117.45 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.784 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.08 9.98 33.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.708 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.94 -150.48 26.87 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.274 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.42 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -178.34 158.46 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.92 0.39 . . . . 0.0 111.073 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.3 28.27 11.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.552 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.9 p90 -62.09 -38.8 90.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.811 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 17.4 t -65.05 -27.0 68.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.984 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.57 -27.29 26.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.62 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.83 27.47 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.699 0.285 . . . . 0.0 110.851 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -128.55 163.57 24.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.1 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -136.83 150.44 48.31 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.66 62.6 1.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.645 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.894 HG22 HD11 ' A' ' 75' ' ' LEU . 6.0 mt -86.02 121.5 37.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.839 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.724 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -143.62 157.77 44.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.105 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 73' ' ' PRO . 13.2 tp -105.15 130.32 53.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.891 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.48 153.88 46.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.002 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.1 145.17 8.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.784 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.1 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.828 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.37 160.12 26.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -17.8 62.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.657 0.265 . . . . 0.0 111.245 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CB ' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -86.37 -7.21 58.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.4 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 66.74 74.37 0.34 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.059 0.457 . . . . 0.0 110.631 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.642 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.7 mm -103.41 125.58 34.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.117 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.484 ' HB2' HD21 ' A' ' 64' ' ' LEU . 56.9 Cg_endo -70.96 102.07 1.17 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.497 2.131 . . . . 0.0 112.361 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.8 118.01 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.232 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.894 HD11 HG22 ' A' ' 62' ' ' ILE . 26.1 tp -88.98 117.38 27.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.722 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -116.74 134.17 55.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.07 146.8 6.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.07 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -74.37 108.63 7.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.747 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 89' ' ' ALA . 41.2 mt -95.02 152.06 18.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.219 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -102.0 110.21 61.77 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.614 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 68.1 Cg_endo -74.11 167.33 27.44 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.551 2.167 . . . . 0.0 112.379 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -76.13 -23.33 54.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.954 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.01 -40.64 60.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.862 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.53 158.23 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.433 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 63.5 112.3 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.474 0.178 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.411 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 40.6 Cg_endo -67.23 144.31 68.11 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.433 2.089 . . . . 0.0 112.26 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.9 m -123.3 156.94 29.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.17 113.45 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.792 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.44 144.86 31.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -141.26 122.36 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.6 p -129.7 134.28 63.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -92.34 107.92 19.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.284 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.778 HD13 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -48.81 -39.2 24.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.047 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.444 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 2.2 p -59.6 -13.65 10.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.501 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -62.56 -46.09 89.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 0.0 111.338 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.642 ' HA ' HD22 ' A' ' 107' ' ' LEU . 6.9 mmm180 -139.98 38.71 1.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.585 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.488 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.82 117.73 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.651 0.263 . . . . 0.0 110.427 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.56 -177.21 16.82 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.94 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -132.05 103.94 6.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.662 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -93.63 116.86 29.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.976 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 7.7 t 54.08 30.54 12.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.22 -15.6 61.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.63 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.6 m -86.63 149.96 24.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.857 0.36 . . . . 0.0 110.865 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.85 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -75.39 126.66 31.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.6 pt -131.51 173.98 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.102 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.41 138.65 54.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.612 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.0 mp -67.79 101.4 1.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.503 ' N ' HD21 ' A' ' 107' ' ' LEU . 22.0 mtp . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.55 56.06 4.46 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.311 179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -59.16 -14.98 12.14 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.136 -0.532 . . . . 0.0 111.096 178.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CE2' HD11 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -45.43 -33.3 2.53 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 120.712 0.292 . . . . 0.0 111.399 -178.328 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.588 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.65 -39.78 94.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.967 0.413 . . . . 0.0 110.651 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.429 ' CG ' ' O ' ' A' ' 3' ' ' ASN . 1.7 pt-20 -77.23 -22.19 52.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.102 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.14 16.46 22.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.387 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.452 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 19.6 t -132.55 159.16 40.27 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.889 0.376 . . . . 0.0 110.94 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -122.35 159.74 26.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.639 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 60.21 58.82 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.004 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 mm -93.2 116.86 35.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.559 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 9.9 p-90 -162.04 171.5 17.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.888 HD11 HD11 ' A' ' 37' ' ' LEU . 7.7 tp -120.06 144.91 47.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.066 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -114.64 120.12 39.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.623 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 60.65 17.78 7.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.175 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.546 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 59.91 56.74 23.09 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.135 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.508 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.22 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.564 0.221 . . . . 0.0 111.496 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' CE1' ' A' ' 17' ' ' HIS . 20.9 mm -101.53 127.03 55.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.9 0.381 . . . . 0.0 110.847 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.843 HD13 ' N ' ' A' ' 20' ' ' HIS . 2.6 tm? -106.97 138.49 43.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.031 -179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.843 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -136.59 132.52 35.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.366 179.488 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -162.02 140.81 9.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.269 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -91.76 97.94 11.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 13.0 m -104.02 132.33 50.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.012 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.23 -178.29 41.95 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.404 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.99 4.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.821 0.343 . . . . 0.0 110.789 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.67 -27.64 1.32 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.243 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.36 -29.97 70.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.96 -4.94 6.08 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.708 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -102.13 165.53 11.1 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -105.98 155.72 19.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.961 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.8 t -134.33 114.56 18.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.229 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -66.04 115.53 6.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.155 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.494 ' HB2' HD23 ' A' ' 104' ' ' LEU . 70.9 m -128.63 169.33 14.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.469 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 68.4 p -149.66 152.27 35.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.969 0.414 . . . . 0.0 111.301 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.67 142.93 41.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.61 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.518 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.5 t0 -100.44 124.95 46.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.144 0.497 . . . . 0.0 110.81 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.92 ' HB3' HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -88.44 -28.03 21.15 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.7 179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -57.02 -10.16 1.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.863 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.2 OUTLIER -129.24 0.27 5.14 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.742 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.501 ' CD1' ' CZ ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -125.41 -1.94 7.49 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.537 0.208 . . . . 0.0 111.437 179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.92 HD12 ' HB3' ' A' ' 37' ' ' LEU . 69.0 mt -140.88 136.95 34.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.796 0.331 . . . . 0.0 110.836 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.22 -179.66 15.92 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.8 t-20 -102.46 111.95 24.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.842 0.353 . . . . 0.0 110.985 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -111.76 98.12 7.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.884 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.3 t70 60.12 46.93 10.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 110.8 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.73 18.48 72.26 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.525 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 m -128.27 163.66 24.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.873 0.368 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD2' HG12 ' A' ' 91' ' ' VAL . 21.8 m-85 -79.79 141.06 36.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.942 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.99 125.76 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.971 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 35.2 m95 -75.73 118.18 18.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.77 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.99 10.25 35.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.734 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.59 -149.2 25.35 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.33 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.33 156.92 0.77 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 111.014 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 65.21 27.15 12.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.01 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.1 p90 -60.71 -42.83 98.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.751 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.536 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.7 t -67.81 -25.81 65.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.029 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.6 -26.59 10.57 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.556 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.46 27.35 5.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.343 . . . . 0.0 110.802 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -127.44 159.86 33.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.03 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.4 p -129.18 153.5 47.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.017 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 38.93 65.8 0.61 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.716 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.878 HG22 HD11 ' A' ' 75' ' ' LEU . 9.7 mt -92.94 114.55 29.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.052 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.681 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.21 157.82 45.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.072 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.577 HD21 ' CB ' ' A' ' 73' ' ' PRO . 6.8 tp -105.15 128.28 53.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.92 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -128.48 153.9 46.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.54 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.6 mm -84.88 145.06 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.724 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.77 134.78 16.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 100.31 162.71 28.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.539 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -73.9 -10.8 60.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.587 0.232 . . . . 0.0 111.299 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.649 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -96.17 -9.28 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.379 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.54 ' HA ' HG23 ' A' ' 66' ' ' ILE . 33.9 m-80 66.29 78.13 0.27 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.023 0.439 . . . . 0.0 110.654 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.8 mm -109.77 117.87 51.38 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.005 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.577 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.2 Cg_endo -59.58 102.44 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.42 2.08 . . . . 0.0 112.147 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -105.88 115.9 48.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.307 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.878 HD11 HG22 ' A' ' 62' ' ' ILE . 69.2 tp -84.28 116.22 22.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.705 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -117.41 132.2 56.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.778 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.07 151.34 8.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.152 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -75.86 118.86 19.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.615 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.765 HD12 ' CB ' ' A' ' 89' ' ' ALA . 22.2 mt -106.34 148.81 27.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.221 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -93.78 106.24 20.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.552 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 73.9 Cg_endo -74.99 167.6 26.69 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.388 2.059 . . . . 0.0 112.495 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.4 ptp -76.58 -23.38 53.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.901 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -74.83 -33.71 62.2 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.812 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 124.82 158.66 10.12 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 63.96 103.8 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.592 0.234 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.402 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 78.0 Cg_exo -50.14 148.85 12.96 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.522 2.148 . . . . 0.0 112.393 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 9.6 p -130.42 148.36 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -68.67 113.59 6.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.938 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.765 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.5 140.63 38.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.35 126.46 24.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.534 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.6 p -136.94 135.85 47.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.258 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.552 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -92.69 108.03 19.67 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.346 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 66.3 mt -48.71 -38.5 21.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.984 0.421 . . . . 0.0 111.065 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -59.9 -13.5 11.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.448 179.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -62.0 -45.76 92.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.677 0.275 . . . . 0.0 111.238 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' HD22 ' A' ' 107' ' ' LEU . 7.3 mmm180 -140.24 38.37 1.91 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.535 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.483 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 29.8 mm -124.83 117.78 51.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.642 0.258 . . . . 0.0 110.435 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -117.71 -177.24 17.35 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.0 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -134.63 102.24 5.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.0 110.706 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -92.4 116.89 29.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.99 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 23.4 t 54.06 31.61 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.068 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.25 -15.75 61.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.625 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 28.3 m -86.5 141.46 29.07 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.801 0.334 . . . . 0.0 110.847 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.494 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.83 123.93 24.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.7 pt -127.1 175.17 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.271 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -128.1 138.82 52.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.557 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 96' ' ' ARG . 9.8 mp -67.82 108.0 2.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.112 -179.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.802 0.334 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.485 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -94.41 62.17 1.75 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.623 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -61.3 -15.35 34.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.851 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.533 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.7 -33.2 2.83 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.668 0.27 . . . . 0.0 111.231 -178.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.593 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -61.62 -35.88 79.15 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.854 0.359 . . . . 0.0 110.663 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.86 -23.62 38.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.166 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -108.95 13.24 24.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.476 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.531 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 25.4 t -125.46 156.91 38.16 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.884 0.373 . . . . 0.0 110.903 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.409 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 5.5 t30 -122.19 159.97 26.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.545 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.593 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.1 OUTLIER 58.35 57.57 3.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.721 0.772 . . . . 0.0 110.784 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 8' ' ' SER . 1.1 mm -92.57 116.76 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.348 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.541 ' O ' HD22 ' A' ' 19' ' ' LEU . 6.3 p-90 -162.46 -173.38 3.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.837 0.351 . . . . 0.0 111.017 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 37' ' ' LEU . 6.8 tp -132.92 141.04 48.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.155 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.9 tt0 -112.54 121.46 44.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.609 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.467 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 59.88 18.04 7.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.066 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.445 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.01 56.45 24.64 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.091 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.482 ' CE1' HG12 ' A' ' 18' ' ' ILE . 8.7 p-80 -176.4 -30.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.663 0.232 . . . . 0.0 111.597 179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.492 ' O ' HD12 ' A' ' 13' ' ' LEU . 23.1 mm -102.31 132.1 49.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.942 0.401 . . . . 0.0 111.212 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.34 137.96 47.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.736 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.679 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -138.58 133.05 32.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.716 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.531 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 143.66 3.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.518 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.3 pt-20 -98.58 107.27 19.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.969 0.414 . . . . 0.0 110.728 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 12.5 m -102.31 147.75 26.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.014 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.3 170.32 48.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.505 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -107.25 -26.81 10.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.748 0.309 . . . . 0.0 110.843 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 117.61 12.55 7.91 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.707 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -111.85 -24.76 9.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 111.064 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.59 -6.1 4.51 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.824 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -114.03 162.22 16.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.759 0.314 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -109.93 157.82 18.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.941 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.61 122.61 47.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.342 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.91 119.36 14.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.736 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.765 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -127.51 162.32 26.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.923 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 60.3 p -148.29 141.58 25.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.5 OUTLIER -129.06 138.33 51.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.132 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 9.1 t0 -96.63 124.64 40.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.591 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.099 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.43 -27.57 21.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -57.21 -12.53 2.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.67 3.14 5.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.586 179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.575 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -118.23 -27.15 6.12 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.083 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.795 HD12 ' HB3' ' A' ' 37' ' ' LEU . 9.8 mt -121.82 142.12 39.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.935 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.01 176.68 18.29 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.72 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -94.71 107.38 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.849 0.357 . . . . 0.0 110.909 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -112.01 97.82 6.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.773 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.0 t0 55.58 47.03 21.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.926 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 87' ' ' VAL . . . 67.99 18.7 71.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.471 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.3 t -128.69 163.58 24.79 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.327 . . . . 0.0 110.845 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 91' ' ' VAL . 20.8 m-85 -82.11 140.49 33.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.938 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.97 125.71 34.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.963 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 40.6 m95 -74.35 117.93 16.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.783 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.39 10.23 34.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.695 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.66 -151.88 28.64 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.262 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.422 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.7 pt-20 -178.52 158.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.848 0.356 . . . . 0.0 111.091 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 65.43 29.16 11.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.073 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.601 ' HE2' HG21 ' A' ' 62' ' ' ILE . 18.3 p90 -62.61 -42.24 99.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.772 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 45.0 t -65.06 -24.17 67.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -50.83 -25.79 9.99 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.664 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 29.93 3.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.784 0.326 . . . . 0.0 110.925 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.607 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -120.68 165.87 14.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.081 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 66.7 m -138.96 150.16 45.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.31 64.02 0.88 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.611 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.036 HG22 HD11 ' A' ' 75' ' ' LEU . 3.2 mt -87.74 117.14 31.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.72 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -143.63 160.01 41.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.088 -179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.665 HD21 ' HB2' ' A' ' 73' ' ' PRO . 9.4 tp -104.9 135.4 46.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.947 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.527 ' O ' HG12 ' A' ' 74' ' ' VAL . 1.2 m-20 -128.55 153.98 46.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.113 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 71' ' ' ASN . 3.9 mm -88.81 130.02 38.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.555 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.68 143.59 47.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.92 154.78 29.29 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.98 -12.83 62.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.602 0.239 . . . . 0.0 111.268 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.47 -6.56 52.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.365 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.448 ' HA ' HG23 ' A' ' 66' ' ' ILE . 20.3 m-80 67.18 77.36 0.27 Allowed 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 121.049 0.452 . . . . 0.0 110.623 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.593 HD13 ' CE1' ' A' ' 5' ' ' HIS . 2.9 mm -105.4 117.42 58.26 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.139 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.665 ' HB2' HD21 ' A' ' 64' ' ' LEU . 37.6 Cg_endo -65.82 103.03 0.55 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.402 2.068 . . . . 0.0 112.0 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.573 ' C ' HD12 ' A' ' 64' ' ' LEU . 3.1 p -111.57 133.34 57.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.416 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 1.036 HD11 HG22 ' A' ' 62' ' ' ILE . 45.2 tp -94.55 130.16 41.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.917 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -124.32 137.78 54.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.01 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.783 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.16 151.42 8.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -82.58 103.3 12.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.363 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.759 HD12 ' CB ' ' A' ' 89' ' ' ALA . 36.6 mt -92.0 146.96 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.472 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -93.71 106.85 23.37 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.451 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.86 166.16 28.68 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.485 2.124 . . . . 0.0 112.403 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 5.6 ptp -76.74 -22.57 53.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.884 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.46 -44.07 62.86 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.778 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.58 154.18 6.71 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.612 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 64.78 111.35 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.59 0.234 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.04 147.85 25.49 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.436 2.091 . . . . 0.0 112.257 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 46' ' ' GLY . 13.7 m -129.23 138.45 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.076 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -65.59 113.31 4.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.759 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.43 141.02 37.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.991 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.45 122.27 17.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.947 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.51 131.6 65.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.151 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.531 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.1 t30 -87.95 107.31 18.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.465 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.509 HD23 ' CD1' ' A' ' 64' ' ' LEU . 3.9 mm? -48.79 -38.32 21.64 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.407 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 1.5 p -59.67 -13.49 10.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.4 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -63.74 -45.73 88.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.617 0.246 . . . . 0.0 111.539 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -138.71 38.42 2.2 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.635 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.533 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.6 mm -124.92 118.04 51.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 110.598 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.419 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.33 179.5 17.01 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.957 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -132.91 102.48 5.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.762 0.315 . . . . 0.0 110.67 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -92.19 116.83 29.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.068 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.8 t 53.48 31.07 11.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.064 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.09 -15.96 61.64 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.649 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.8 m -86.58 143.15 27.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 0.0 110.819 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.765 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.8 OUTLIER -72.97 128.42 35.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.969 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.0 pt -134.26 169.98 20.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.066 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -120.28 138.56 53.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.2 mm? -68.0 106.36 2.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.823 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.104 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.771 0.32 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.48 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -88.29 62.7 3.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.567 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -61.75 -15.16 38.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.835 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.58 -32.92 2.53 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-O 120.752 0.31 . . . . 0.0 111.361 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.607 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.6 p80 -62.54 -35.1 78.36 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.43 -24.51 39.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.152 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.48 15.41 23.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.404 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.589 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 43.3 t -130.37 154.64 47.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.883 0.373 . . . . 0.0 110.866 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 4.3 t30 -121.33 160.14 24.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.491 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.578 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 60.32 58.93 2.43 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.677 0.751 . . . . 0.0 110.808 -179.543 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' A' ' 73' ' ' PRO . 1.1 mm -93.37 116.89 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.583 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.447 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.8 p-90 -162.38 -172.43 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.126 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -134.07 145.6 49.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.479 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 52.1 tt0 -118.31 121.83 41.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.679 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.2 OUTLIER 60.54 18.05 7.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.109 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.441 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 60.1 55.41 30.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.135 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.473 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.5 p-80 -176.32 -31.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.685 0.243 . . . . 0.0 111.6 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG12 ' CE1' ' A' ' 17' ' ' HIS . 22.9 mm -103.38 129.29 55.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.933 0.397 . . . . 0.0 111.092 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.08 140.19 44.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.731 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.479 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -135.11 135.1 40.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.17 145.21 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.525 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.449 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 21.6 pt-20 -99.51 107.88 20.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.938 0.399 . . . . 0.0 110.887 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.0 m -108.61 135.18 50.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.033 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.24 174.87 54.91 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.315 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -113.28 -37.18 4.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.54 -24.35 2.0 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.25 -28.18 68.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.5 0.69 7.28 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.593 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.85 163.98 13.59 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.838 0.352 . . . . 0.0 110.747 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.404 ' CD2' ' HG3' ' A' ' 22' ' ' GLU . 2.9 m-30 -104.49 157.64 17.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 t -136.09 114.56 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.338 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.0 115.36 6.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.998 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.618 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.8 m -125.4 160.86 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 20' ' ' HIS . 64.8 p -144.5 143.47 30.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.33 138.52 53.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.113 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 43.7 t0 -96.63 123.45 40.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.514 179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.01 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.54 -27.87 21.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -57.29 -12.81 2.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.591 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.06 2.13 5.88 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.01 -23.46 6.87 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 120.688 0.28 . . . . 0.0 111.143 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.764 HD12 ' HB3' ' A' ' 37' ' ' LEU . 10.6 mt -125.97 141.74 44.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.0 178.69 16.73 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.694 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.427 ' ND2' HD22 ' A' ' 79' ' ' LEU . 23.2 t-20 -97.38 107.93 20.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.778 0.323 . . . . 0.0 110.975 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -111.96 97.8 6.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.88 179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.7 56.76 7.16 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.183 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.91 18.02 52.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.567 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.8 164.07 22.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.816 0.341 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD1' HD11 ' A' ' 79' ' ' LEU . 18.1 m-85 -84.67 142.38 29.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.96 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 77.4 p -130.91 125.66 34.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CH2' HG12 ' A' ' 97' ' ' ILE . 29.9 m95 -75.78 118.27 18.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.835 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.02 11.02 35.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.754 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.54 -150.58 27.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.41 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 4.0 pt-20 -178.27 157.29 1.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.866 0.365 . . . . 0.0 111.057 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 66.77 27.31 9.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.04 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HE2' HG21 ' A' ' 62' ' ' ILE . 14.8 p90 -62.37 -44.85 95.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.794 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.456 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 36.7 t -64.32 -26.94 68.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.014 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -52.38 -25.41 19.62 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.595 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.54 28.54 5.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.749 0.309 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -126.05 166.97 15.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.06 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 70.2 m -137.91 150.38 47.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.064 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.33 64.63 0.79 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.611 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.94 HG22 HD11 ' A' ' 75' ' ' LEU . 4.4 mt -89.0 119.01 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.687 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.93 158.32 44.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -179.83 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' CD1' HD23 ' A' ' 93' ' ' LEU . 4.5 tp -108.2 129.18 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.511 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.2 mm -84.86 144.75 9.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.661 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -147.48 136.19 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.1 170.43 33.63 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.544 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -81.96 -10.92 59.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.623 0.249 . . . . 0.0 111.361 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.624 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -94.88 -5.86 43.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.416 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.511 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.6 m-80 65.0 78.6 0.28 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.028 0.442 . . . . 0.0 110.591 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.624 HD11 ' HB3' ' A' ' 70' ' ' ASP . 3.1 mm -109.2 116.18 55.55 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.096 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.612 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.0 Cg_endo -59.83 102.32 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.507 2.138 . . . . 0.0 112.326 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.3 t -103.68 122.28 56.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 62' ' ' ILE . 28.5 tp -90.58 116.26 28.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.742 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 29.3 mtm180 -117.41 135.03 54.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.06 156.15 12.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -82.44 105.79 13.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.699 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.821 HD23 ' HB2' ' A' ' 59' ' ' ALA . 33.7 mt -92.01 144.89 24.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.152 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -93.32 108.35 32.67 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.719 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.38 167.61 26.74 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.532 2.155 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.86 -24.56 59.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.96 -33.62 59.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.872 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 127.21 162.97 11.32 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.511 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 63.71 124.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.572 0.225 . . . . 0.0 110.807 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.39 141.01 72.72 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.439 2.093 . . . . 0.0 112.248 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.66 139.15 46.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -66.26 107.9 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.669 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.694 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.41 140.75 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.011 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.97 122.3 15.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.784 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.49 132.4 62.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.191 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.575 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.9 t30 -88.03 108.73 19.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.407 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.671 HD23 ' CD1' ' A' ' 64' ' ' LEU . 4.1 mm? -48.93 -39.28 25.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.052 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 2' ' ' GLY . 10.9 m -59.84 -13.69 11.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.343 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -60.2 -47.52 85.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.686 0.279 . . . . 0.0 111.381 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 2.5 mmm180 -140.29 39.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.503 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.8 mm -124.84 117.93 51.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.732 0.301 . . . . 0.0 110.563 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.478 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.62 -176.49 16.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.77 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -137.63 103.2 4.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.748 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -95.24 116.87 29.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.006 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 5.5 t 56.08 30.61 16.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.008 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.77 -15.38 61.78 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.696 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 44.8 m -86.62 143.23 27.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.817 0.341 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.618 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.5 OUTLIER -72.87 127.11 31.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.91 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.4 pt -130.96 173.96 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.037 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 2.5 t80 -125.21 138.52 54.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.653 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.422 HD13 ' HA ' ' A' ' 107' ' ' LEU . 4.1 mm? -67.92 95.53 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.41 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.088 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.757 0.313 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -80.29 62.91 4.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.502 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -62.29 -15.24 46.46 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.103 -0.549 . . . . 0.0 110.882 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.64 -33.16 2.74 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.337 -178.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.545 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.0 p80 -64.62 -37.6 88.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.875 0.369 . . . . 0.0 110.91 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -20.91 48.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.392 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.71 16.69 19.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.451 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.596 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 45.3 t -127.96 156.81 42.09 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.877 0.37 . . . . 0.0 110.917 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t30 -120.98 159.98 24.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.446 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.586 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.2 OUTLIER 57.21 57.77 4.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.718 0.771 . . . . 0.0 110.69 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.461 HD11 ' C ' ' A' ' 8' ' ' SER . 1.5 mm -92.01 116.98 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.623 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.453 ' CE2' ' ND1' ' A' ' 20' ' ' HIS . 9.7 p-90 -162.17 -171.51 2.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.031 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 37' ' ' LEU . 8.0 tp -137.98 143.24 40.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.153 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.456 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 35.1 tt0 -113.02 122.8 48.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.593 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.46 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.4 OUTLIER 59.59 18.26 6.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.096 -179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 60.17 55.35 30.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.113 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.605 ' HA ' HD12 ' A' ' 37' ' ' LEU . 7.4 p-80 -175.73 -32.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.55 0.214 . . . . 0.0 111.491 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.6 mm -102.95 125.86 57.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.854 0.359 . . . . 0.0 110.924 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.523 HD12 HD13 ' A' ' 93' ' ' LEU . 8.5 tt -107.17 142.89 36.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -137.66 134.2 35.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.377 179.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.15 145.22 4.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.639 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 1.0 OUTLIER -102.41 109.01 20.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.038 0.446 . . . . 0.0 110.618 179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.2 m -106.42 142.21 36.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.956 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.36 168.49 40.43 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.364 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.05 -37.89 4.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.785 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.57 -22.86 2.84 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.021 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -63.65 -25.67 68.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.881 0.372 . . . . 0.0 110.982 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.23 3.33 8.83 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.453 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -124.82 163.72 21.56 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.789 0.328 . . . . 0.0 110.672 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' CD2' ' OE2' ' A' ' 22' ' ' GLU . 4.6 m-85 -105.65 157.91 17.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.045 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.58 115.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.391 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -65.03 116.45 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.928 ' HB2' HD23 ' A' ' 104' ' ' LEU . 48.0 m -123.97 163.72 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.079 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.4 p -149.72 138.25 20.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.685 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.92 137.72 54.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.2 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.497 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 11.0 t0 -99.04 123.74 43.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.54 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -28.11 21.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.816 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.1 -12.01 1.92 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -129.35 1.37 5.11 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.715 179.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.502 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.51 -24.59 6.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.646 0.26 . . . . 0.0 111.234 179.722 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.829 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.5 mt -122.73 142.69 38.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.008 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.25 177.61 17.85 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.509 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.49 ' CG ' HD22 ' A' ' 79' ' ' LEU . 62.8 t-20 -103.96 110.82 23.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -111.81 98.16 7.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 59.52 45.09 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.848 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.86 17.91 75.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.548 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 8.2 t -128.83 149.77 50.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.84 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' HD11 ' A' ' 79' ' ' LEU . 22.9 m-85 -69.97 141.69 52.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -130.96 126.07 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.0 m95 -74.54 119.35 18.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.768 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.36 11.5 38.64 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.736 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.52 -148.42 24.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.196 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' CB ' ' HA ' ' A' ' 39' ' ' TYR . 6.4 pt-20 179.97 157.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.102 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 63.35 29.48 15.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.995 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' HE2' HG21 ' A' ' 62' ' ' ILE . 19.3 p90 -60.93 -39.02 87.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.759 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 27.5 t -67.99 -23.73 65.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.09 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -49.25 -27.08 7.15 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.609 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.64 29.11 4.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.817 0.342 . . . . 0.0 110.81 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 62' ' ' ILE . . . -122.95 159.6 27.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 90.5 p -130.63 150.17 51.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 37.78 64.33 0.68 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.776 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.99 HG22 HD11 ' A' ' 75' ' ' LEU . 6.5 mt -85.77 119.42 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.721 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.616 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.01 159.96 41.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 111.328 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 ' HB2' ' A' ' 73' ' ' PRO . 19.5 tp -104.72 131.41 52.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.805 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' O ' HG12 ' A' ' 74' ' ' VAL . 57.9 m-20 -128.68 153.99 46.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.073 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.551 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.7 mm -85.07 144.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -143.38 147.4 34.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 80.26 163.21 27.95 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.552 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.19 -7.3 53.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.6 0.238 . . . . 0.0 111.327 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -95.39 -4.17 45.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.281 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.551 ' HA ' HG23 ' A' ' 66' ' ' ILE . 21.5 m-80 64.76 79.69 0.25 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.021 0.439 . . . . 0.0 110.623 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.631 HD11 ' HB3' ' A' ' 70' ' ' ASP . 4.3 mm -108.75 117.76 53.32 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.279 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.679 ' HB2' HD21 ' A' ' 64' ' ' LEU . 38.0 Cg_endo -65.96 103.73 0.64 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.361 2.041 . . . . 0.0 111.855 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.675 ' C ' HD12 ' A' ' 64' ' ' LEU . 5.3 p -113.43 130.88 66.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.568 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 62' ' ' ILE . 45.4 tp -88.89 131.31 35.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.892 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.09 132.12 46.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.055 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.802 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.12 150.97 8.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.017 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -76.9 108.19 9.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.781 HD12 ' CB ' ' A' ' 89' ' ' ALA . 30.0 mt -91.94 149.46 21.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -97.89 102.97 14.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.839 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.24 164.46 31.05 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.41 2.073 . . . . 0.0 112.331 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.96 2.55 55.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.377 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -97.34 -49.34 4.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.793 0.33 . . . . 0.0 111.073 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.97 -127.08 2.67 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.68 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 6.8 m-20 -104.71 163.92 16.25 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.052 0.453 . . . . 0.0 110.784 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 85' ' ' ASP . 1.0 OUTLIER -38.74 144.69 0.2 Allowed 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 123.987 3.124 . . . . 0.0 112.812 179.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 88' ' ' GLU . 10.0 p -138.06 155.93 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 87' ' ' VAL . 2.1 tt0 -77.04 112.35 13.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.781 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -106.7 140.52 39.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -139.72 122.27 16.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.022 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG12 ' CD2' ' A' ' 48' ' ' PHE . 13.8 p -131.15 129.99 63.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.163 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.3 t30 -86.08 110.11 19.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.513 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.523 HD13 HD12 ' A' ' 19' ' ' LEU . 68.0 mt -50.99 -38.27 50.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 12.1 m -59.56 -13.54 9.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.404 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.29 -45.65 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 0.0 111.4 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -139.3 38.45 2.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.514 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 29.5 mm -124.93 117.86 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.732 0.301 . . . . 0.0 110.544 179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.58 -178.11 16.42 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.821 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -134.6 103.37 5.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -92.86 116.92 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.01 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.9 t 54.87 30.6 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.027 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.79 -15.87 61.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.661 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 26.3 m -86.81 143.34 27.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.76 0.314 . . . . 0.0 110.886 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.928 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.1 mm? -72.89 128.7 36.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 pt -135.27 171.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 108' ' ' ALA . 3.0 t80 -121.09 138.47 54.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.56 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 107' ' ' LEU . 3.5 mm? -68.06 99.47 0.88 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.502 ' HB2' ' CE1' ' A' ' 106' ' ' PHE . . . . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.121 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.782 0.325 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.488 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.44 61.76 4.15 Favored Glycine 0 CA--C 1.509 -0.319 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.56 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -61.37 -15.08 32.75 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.115 -0.542 . . . . 0.0 110.998 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 1.1 p90 -45.6 -32.91 2.54 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.743 0.306 . . . . 0.0 111.408 -178.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.517 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.3 p80 -63.8 -35.59 81.1 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.789 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.88 -24.05 41.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.124 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.6 15.81 23.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.379 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.621 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 46.2 t -131.43 154.47 48.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.865 0.364 . . . . 0.0 110.931 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -122.01 159.65 26.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.703 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 62.47 55.45 2.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 110.745 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.9 OUTLIER -94.73 116.72 36.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.511 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.513 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.6 p-90 -158.25 -173.96 4.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.015 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 37' ' ' LEU . 6.9 tp -129.84 139.53 51.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.968 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.462 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 36.0 tt0 -113.57 118.13 33.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.464 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.5 OUTLIER 60.69 17.8 7.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.208 -179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.5 56.24 26.12 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.979 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.8 p-80 -176.08 -30.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 17' ' ' HIS . 23.0 mm -102.57 132.35 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.924 0.392 . . . . 0.0 111.009 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.3 tm? -111.41 141.24 45.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.003 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.813 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.85 133.88 34.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.441 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.621 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -167.73 137.39 2.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.294 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.42 106.92 18.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.1 m -106.07 138.68 41.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.129 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -77.06 173.72 54.78 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.558 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -112.4 -26.58 8.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.697 0.284 . . . . 0.0 111.116 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 118.54 16.96 5.35 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.816 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -112.43 -22.39 10.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 111.114 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.61 0.12 5.78 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.896 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.87 163.46 21.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.792 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 3.6 m-85 -108.51 157.57 18.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t -132.47 114.66 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.296 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -63.96 132.14 49.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.004 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.703 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -143.81 165.8 26.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 61.0 p -149.14 146.96 27.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.996 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.744 HD21 ' CD2' ' A' ' 40' ' ' TYR . 0.6 OUTLIER -133.03 139.77 47.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.51 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t0 -94.46 124.43 38.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.106 0.479 . . . . 0.0 110.587 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 1.032 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.45 -27.61 21.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.718 179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -57.49 -12.37 2.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.666 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.51 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.83 2.78 5.39 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.572 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.744 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -118.21 -25.49 6.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.633 0.254 . . . . 0.0 111.206 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.741 HD12 ' HB3' ' A' ' 37' ' ' LEU . 12.2 mt -123.32 144.69 32.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.808 0.337 . . . . 0.0 111.114 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.63 178.16 18.07 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.573 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' ND2' HD22 ' A' ' 79' ' ' LEU . 60.6 t-20 -102.18 110.93 23.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.877 0.37 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -111.83 98.22 7.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.8 t0 58.31 51.01 8.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.49 17.52 66.68 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.57 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.3 m -128.17 163.17 25.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.836 0.351 . . . . 0.0 110.878 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' HG12 ' A' ' 91' ' ' VAL . 23.6 m-85 -81.23 142.55 33.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 51.6 p -130.98 125.06 32.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.019 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CH2' HG12 ' A' ' 97' ' ' ILE . 28.8 m95 -74.76 118.21 17.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.734 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.78 12.81 33.81 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.607 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.1 -147.72 23.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.224 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -179.64 156.1 0.68 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.878 0.371 . . . . 0.0 111.227 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 63.39 29.26 15.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.655 ' HE2' HG21 ' A' ' 62' ' ' ILE . 21.4 p90 -60.63 -39.69 89.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.748 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 28.8 t -70.93 -24.51 62.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.114 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.39 -25.62 12.99 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.698 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.47 30.05 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.724 0.297 . . . . 0.0 111.034 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.839 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -127.93 167.45 16.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.081 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -137.4 155.0 49.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.38 63.65 0.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.665 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.887 HG22 HD11 ' A' ' 75' ' ' LEU . 5.5 mt -90.29 114.86 28.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.003 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.668 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -141.03 159.85 41.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.037 -179.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.649 HD11 HD23 ' A' ' 93' ' ' LEU . 12.7 tp -105.15 129.81 53.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.954 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -128.47 153.97 46.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.572 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.4 mm -84.76 144.11 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.733 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.14 145.71 44.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.04 165.51 12.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.559 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -76.39 -6.78 53.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.597 0.237 . . . . 0.0 111.411 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.8 m-20 -88.22 -10.24 50.39 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.572 ' HA ' HG23 ' A' ' 66' ' ' ILE . 22.1 m-80 66.32 74.27 0.35 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.075 0.464 . . . . 0.0 110.845 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' A' ' 70' ' ' ASP . 2.5 mm -107.88 119.17 51.0 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.954 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . 28.5 Cg_endo -62.65 102.48 0.29 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.439 2.092 . . . . 0.0 112.116 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.2 t -107.08 126.18 63.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.385 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.887 HD11 HG22 ' A' ' 62' ' ' ILE . 25.6 tp -92.09 116.82 29.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.659 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -117.31 132.18 56.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.989 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.11 149.79 7.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -75.98 115.09 15.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.655 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 59' ' ' ALA . 29.2 mt -102.4 146.78 27.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.191 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -92.83 107.05 21.59 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.646 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 74.1 Cg_endo -75.71 167.56 26.11 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.515 2.143 . . . . 0.0 112.468 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.1 ptp -78.24 -22.17 48.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.876 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.85 -54.41 11.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.816 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 152.18 147.1 4.5 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.576 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 t0 64.56 121.1 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.574 0.226 . . . . 0.0 110.913 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.407 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 51.3 Cg_exo -54.21 161.18 5.49 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.456 2.104 . . . . 0.0 112.292 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 t -138.89 144.96 28.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.33 110.48 4.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.696 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.36 140.6 38.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.066 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.58 122.28 17.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -131.24 132.07 63.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.208 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.557 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.4 t30 -87.98 108.17 19.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.414 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.649 HD23 HD11 ' A' ' 64' ' ' LEU . 4.0 mm? -48.37 -39.04 20.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 2' ' ' GLY . 13.6 m -60.18 -13.52 12.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.419 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.75 -47.06 88.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.672 0.273 . . . . 0.0 111.428 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -140.25 39.73 1.92 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.497 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.505 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.4 mm -124.89 117.79 51.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.701 0.286 . . . . 0.0 110.412 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -119.4 -176.86 16.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.93 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -133.78 104.78 6.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.816 0.341 . . . . 0.0 110.694 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -93.39 116.79 29.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 12.8 t 54.35 31.1 13.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.027 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.3 -15.99 60.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.688 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 41.2 m -86.68 146.04 26.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.821 0.343 . . . . 0.0 110.957 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.703 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.7 OUTLIER -72.97 128.95 36.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.937 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -135.31 173.77 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.037 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -124.27 138.48 54.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.674 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 8.4 mp -68.04 98.22 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.071 -179.964 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' N ' HD21 ' A' ' 107' ' ' LEU . 8.6 mmt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.715 0.293 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.481 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -82.11 61.54 4.67 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -62.24 -15.15 45.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.908 178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -45.65 -33.65 3.03 Favored 'General case' 0 CA--C 1.527 0.064 0 CA-C-O 120.718 0.294 . . . . 0.0 111.307 -178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 72' ' ' ILE . 3.6 p80 -61.66 -35.25 77.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 0.0 110.691 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -24.22 39.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -109.93 14.6 23.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.463 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.584 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 34.0 t -126.84 154.22 44.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.94 0.4 . . . . 0.0 110.96 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.443 ' O ' ' ND2' ' A' ' 10' ' ' ASN . 4.3 t30 -121.47 160.22 24.63 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.506 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.568 ' O ' ' CG ' ' A' ' 10' ' ' ASN . 0.3 OUTLIER 60.23 58.55 2.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.742 0.782 . . . . 0.0 110.652 -179.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.563 ' N ' HD13 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -93.36 116.65 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' O ' HD22 ' A' ' 19' ' ' LEU . 8.4 p-90 -163.52 -173.95 3.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.786 0.327 . . . . 0.0 111.126 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 37' ' ' LEU . 7.4 tp -130.55 149.34 52.25 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.166 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 26.7 tt0 -121.35 115.74 23.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.669 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER 65.45 13.28 8.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.3 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 67.19 54.33 21.24 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.374 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.478 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.1 p-80 -176.75 -33.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.871 0.335 . . . . 0.0 111.585 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' O ' HD12 ' A' ' 13' ' ' LEU . 24.6 mm -97.55 131.19 45.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.914 0.388 . . . . 0.0 111.194 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.4 tm? -110.53 138.23 47.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.73 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.659 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -137.16 134.35 36.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.833 0.349 . . . . 0.0 110.845 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.584 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -168.21 145.99 4.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.562 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.424 ' CG ' ' HB3' ' A' ' 9' ' ' ASN . 10.3 pt-20 -102.8 109.5 21.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.846 0.355 . . . . 0.0 110.64 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 6.2 m -104.43 150.54 24.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.972 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 30' ' ' TYR . . . -90.76 169.1 33.57 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.528 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -28.8 8.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.844 0.354 . . . . 0.0 110.866 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.8 -22.27 6.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -69.05 -26.56 65.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.838 0.351 . . . . 0.0 111.013 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.46 -2.25 5.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.813 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -117.54 159.89 22.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.764 0.316 . . . . 0.0 110.764 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.446 ' HA ' ' HA2' ' A' ' 24' ' ' GLY . 6.1 m-85 -106.46 157.9 17.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 t -133.23 122.06 44.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.574 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -72.13 128.84 36.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.619 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -139.32 167.95 20.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.812 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 71.6 p -149.66 148.27 29.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.97 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.48 138.14 46.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.946 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.503 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 1.2 t0 -94.96 123.98 38.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.645 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.973 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.4 -27.99 21.22 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -57.53 -12.22 2.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.665 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' CD1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -128.31 1.62 5.72 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.589 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -118.96 -23.83 6.77 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.667 0.27 . . . . 0.0 111.231 179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.726 HD12 ' HB3' ' A' ' 37' ' ' LEU . 13.1 mt -125.01 143.46 38.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.871 0.367 . . . . 0.0 111.063 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.48 178.6 17.29 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.375 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -103.2 110.5 22.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -111.78 98.08 7.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 38.8 t70 60.89 45.04 10.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 0.0 110.811 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.21 19.57 74.22 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.556 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.24 159.04 36.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.74 0.305 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.7 m-85 -78.03 140.49 39.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.34 40.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.038 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' CH2' HG12 ' A' ' 97' ' ' ILE . 33.5 m95 -77.01 117.98 19.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.96 34.45 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.713 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -95.06 -150.2 26.79 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.322 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -178.67 156.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 110.991 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 65.47 27.2 11.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.071 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.551 ' HE2' HG21 ' A' ' 62' ' ' ILE . 16.5 p90 -60.08 -43.21 95.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.654 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 59' ' ' ALA . 16.3 t -64.0 -17.89 63.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.006 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -47.67 -40.55 17.88 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.6 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.552 ' HB3' ' HB2' ' A' ' 80' ' ' ASN . 0.1 OUTLIER -122.86 32.32 5.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 110.88 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 56' ' ' SER . . . -120.32 158.71 26.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.802 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.1 m -135.02 150.39 50.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.071 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 39.48 61.66 1.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.709 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.992 HG22 HD11 ' A' ' 75' ' ' LEU . 3.8 mt -84.68 120.11 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.599 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.65 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.93 157.86 44.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.934 0.397 . . . . 0.0 111.306 -179.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 73' ' ' PRO . 1.0 OUTLIER -106.8 129.27 54.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.831 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -128.38 153.96 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.053 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.457 HG23 ' HA ' ' A' ' 71' ' ' ASN . 5.9 mm -84.86 142.66 12.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.696 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.96 138.35 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 98.05 172.44 32.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.477 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.99 -18.81 42.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.644 0.259 . . . . 0.0 111.196 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HB3' HD11 ' A' ' 72' ' ' ILE . 1.1 m-20 -89.49 -5.4 57.34 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.361 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' HG23 ' A' ' 66' ' ' ILE . 26.0 m-80 65.24 76.46 0.33 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.014 0.435 . . . . 0.0 110.662 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.54 HG22 ' OD1' ' A' ' 92' ' ' ASN . 3.7 mm -104.41 117.83 58.21 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.065 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.623 ' HB2' HD11 ' A' ' 64' ' ' LEU . 32.4 Cg_endo -64.05 102.57 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.505 2.137 . . . . 0.0 112.223 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 72' ' ' ILE . 25.8 t -104.12 131.08 53.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.378 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.992 HD11 HG22 ' A' ' 62' ' ' ILE . 29.4 tp -96.3 116.14 28.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.615 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.6 mtm180 -114.55 134.09 55.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.248 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.735 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -166.11 145.17 5.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.142 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 mt-10 -74.99 112.92 11.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.642 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.7 HD12 ' CB ' ' A' ' 89' ' ' ALA . 33.8 mt -100.12 148.3 24.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.471 -179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.552 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 25.4 m-80 -95.28 108.54 39.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.579 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.61 163.93 36.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.348 2.032 . . . . 0.0 112.14 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 2.0 ptt? -72.72 -22.86 60.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.099 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.03 -39.82 48.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 135.87 161.78 9.35 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.05 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.514 0.197 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.42 142.09 64.28 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.363 2.042 . . . . 0.0 112.225 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.2 p -122.26 146.16 27.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.082 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -65.56 114.16 4.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.7 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.39 142.9 34.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -139.07 122.28 16.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.973 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.8 p -130.19 132.25 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.084 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.54 ' OD1' HG22 ' A' ' 72' ' ' ILE . 3.1 t30 -87.86 107.33 18.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 74.8 mt -48.64 -38.54 21.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.041 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.416 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 6.9 m -59.55 -13.58 9.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.389 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -62.07 -45.89 91.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.693 0.282 . . . . 0.0 111.257 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.563 ' HA ' HD22 ' A' ' 107' ' ' LEU . 2.9 mmm180 -140.46 38.35 1.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.618 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.519 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 30.5 mm -124.94 117.92 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.755 0.312 . . . . 0.0 110.557 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.83 -179.14 16.86 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.94 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -131.79 103.26 6.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.766 0.317 . . . . 0.0 110.676 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.6 116.89 29.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.995 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 6.6 t 53.7 30.45 11.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.41 -15.98 61.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.651 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.3 m -87.07 146.06 26.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.84 0.352 . . . . 0.0 110.856 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.619 HD23 ' HB2' ' A' ' 33' ' ' SER . 0.6 OUTLIER -72.95 131.09 41.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.976 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.3 pt -137.39 174.15 11.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.078 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -123.7 138.67 54.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.632 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.563 HD22 ' HA ' ' A' ' 96' ' ' ARG . 10.6 mp -67.95 103.18 1.42 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.215 -0.897 . . . . 0.0 111.104 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.817 0.341 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.487 ' CA ' ' O ' ' A' ' 97' ' ' ILE . . . -87.65 62.8 3.96 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.548 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -61.76 -15.22 39.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.146 -0.527 . . . . 0.0 110.902 178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 97' ' ' ILE . 0.9 OUTLIER -45.66 -32.73 2.53 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 120.762 0.315 . . . . 0.0 111.315 -178.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' ILE . 2.5 p80 -63.13 -35.35 80.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.806 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.72 -24.44 41.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.155 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.3 p -108.8 17.14 22.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.353 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.805 ' OG ' ' HB1' ' A' ' 21' ' ' ALA . 40.5 t -129.81 156.88 43.62 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.822 0.344 . . . . 0.0 110.974 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 10' ' ' ASN . 1.8 t30 -121.97 159.8 26.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.629 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.4 ' N ' ' ND2' ' A' ' 9' ' ' ASN . 21.7 m-20 57.0 60.58 2.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.865 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 11' ' ' ILE . 1.1 mm -94.44 116.89 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.699 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.59 ' O ' HD22 ' A' ' 19' ' ' LEU . 7.7 p-90 -161.83 -173.5 3.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 8.5 tp -131.71 147.75 52.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.411 . . . . 0.0 111.115 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.26 119.02 33.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.626 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' HIS . 0.1 OUTLIER 62.05 16.32 8.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.367 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.688 ' HA2' HD23 ' A' ' 13' ' ' LEU . . . 62.5 55.83 25.08 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.302 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.481 ' CE1' HG12 ' A' ' 18' ' ' ILE . 7.6 p-80 -175.94 -33.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.611 0.244 . . . . 0.0 111.421 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.527 ' O ' HD12 ' A' ' 13' ' ' LEU . 20.7 mm -98.37 131.39 45.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.858 0.361 . . . . 0.0 110.951 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 ' N ' ' A' ' 20' ' ' HIS . 3.5 tm? -111.31 137.24 49.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.973 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.691 ' N ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -132.17 135.16 46.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.622 179.68 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.805 ' HB1' ' OG ' ' A' ' 8' ' ' SER . . . -165.66 144.56 6.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.153 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.07 97.78 8.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.773 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.3 m -100.65 131.61 46.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.995 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.84 -179.05 51.27 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.384 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.28 -37.79 4.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.861 0.362 . . . . 0.0 110.722 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.73 -27.43 1.31 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.05 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -64.76 -29.78 70.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 0.0 110.878 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.39 6.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.665 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -104.52 165.56 10.98 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.884 0.373 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -106.05 157.82 17.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.004 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 19.5 t -132.51 121.61 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.397 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -67.46 124.29 22.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.989 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.8 ' HB2' HD23 ' A' ' 104' ' ' LEU . 0.7 OUTLIER -145.14 156.08 43.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.723 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.401 ' HB ' ' O ' ' A' ' 19' ' ' LEU . 70.9 p -144.32 147.43 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.075 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.89 135.8 49.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.962 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.508 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 27.6 t70 -94.02 123.87 37.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.61 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -88.39 -28.37 20.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.739 179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -57.07 -12.77 2.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.628 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CD1' ' O ' ' A' ' 36' ' ' ASP . 0.1 OUTLIER -128.33 1.94 5.71 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.641 179.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CD1' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -119.68 -22.01 7.06 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.565 0.222 . . . . 0.0 111.264 179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.793 HD12 ' HB3' ' A' ' 37' ' ' LEU . 15.3 mt -125.25 141.96 43.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.858 0.361 . . . . 0.0 111.069 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.51 178.21 17.31 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.547 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' ND2' HD22 ' A' ' 79' ' ' LEU . 63.0 t-20 -103.48 111.04 23.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.839 0.352 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -111.85 98.61 7.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.5 t70 61.17 43.59 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.814 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 18.96 76.83 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.79 154.47 46.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.863 0.363 . . . . 0.0 110.926 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.546 ' CD2' HG12 ' A' ' 91' ' ' VAL . 18.1 m-85 -72.25 140.58 48.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.844 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.95 125.37 33.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.054 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CH2' HG12 ' A' ' 97' ' ' ILE . 43.2 m95 -76.21 117.83 18.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.805 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.57 10.21 33.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.729 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -96.59 -147.5 22.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.315 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -179.78 158.85 0.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.817 0.342 . . . . 0.0 110.974 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 63.93 27.5 14.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.003 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.717 ' HE2' HG21 ' A' ' 62' ' ' ILE . 20.6 p90 -60.45 -41.34 93.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.939 0.4 . . . . 0.0 110.762 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HA ' HD11 ' A' ' 62' ' ' ILE . 11.0 t -67.85 -25.0 65.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.978 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -51.03 -26.27 11.39 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -127.28 25.29 6.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.76 0.314 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.706 ' HB2' HD23 ' A' ' 79' ' ' LEU . . . -125.34 168.97 12.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.916 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.7 m -139.54 151.87 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.01 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 39.6 62.29 1.22 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.634 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.924 HG22 HD11 ' A' ' 75' ' ' LEU . 8.5 mt -88.03 116.15 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.11 157.55 45.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.194 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD21 ' CB ' ' A' ' 73' ' ' PRO . 4.1 tp -106.3 128.61 54.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.913 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -128.48 153.89 46.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.01 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.527 HG23 ' HA ' ' A' ' 71' ' ' ASN . 6.8 mm -84.92 145.11 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.661 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.0 130.2 11.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 105.92 159.63 22.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -70.86 -11.39 60.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.557 0.218 . . . . 0.0 111.395 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -96.86 -9.13 29.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.386 -179.912 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 66' ' ' ILE . 23.2 m-80 66.31 78.65 0.26 Allowed 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 120.976 0.417 . . . . 0.0 110.635 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 74' ' ' VAL . 2.9 mm -110.15 115.69 54.35 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.131 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.789 ' CB ' HD21 ' A' ' 64' ' ' LEU . 18.8 Cg_endo -58.33 102.49 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.468 2.112 . . . . 0.0 112.2 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 72' ' ' ILE . 21.4 t -104.52 117.51 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.259 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.924 HD11 HG22 ' A' ' 62' ' ' ILE . 30.4 tp -86.53 117.22 25.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.759 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.403 ' HG2' ' HB3' ' A' ' 90' ' ' ASN . 20.9 mtm180 -118.49 131.99 56.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.041 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.751 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -166.18 142.42 4.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.17 121.53 16.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.638 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.706 HD23 ' HB2' ' A' ' 59' ' ' ALA . 21.9 mt -107.71 150.37 27.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.164 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -95.98 105.46 21.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.558 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' CD ' ' HA ' ' A' ' 86' ' ' PRO . 72.0 Cg_endo -75.9 166.1 28.74 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.486 2.124 . . . . 0.0 112.494 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 6.5 ptm -77.14 -22.24 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.97 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -73.1 -45.78 55.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.833 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.22 155.7 6.74 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.533 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 62.97 107.33 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.558 0.218 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HA ' ' CD ' ' A' ' 81' ' ' PRO . 77.8 Cg_exo -50.57 147.23 17.86 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.478 2.119 . . . . 0.0 112.344 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 14.5 m -128.35 140.04 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.54 114.33 4.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.827 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.703 ' CB ' HD12 ' A' ' 79' ' ' LEU . . . -105.45 144.1 32.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' HB3' ' HG2' ' A' ' 76' ' ' ARG . 0.6 OUTLIER -139.07 122.27 16.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 48' ' ' PHE . 14.5 p -131.51 130.89 62.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.175 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.582 ' OD1' HG22 ' A' ' 72' ' ' ILE . 2.7 t30 -87.2 108.79 19.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.374 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.449 HD11 HD13 ' A' ' 64' ' ' LEU . 73.5 mt -48.85 -38.86 23.57 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.059 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.415 ' O ' ' HA3' ' A' ' 2' ' ' GLY . 9.8 m -60.07 -13.61 12.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.309 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -60.68 -46.81 88.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.223 -179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -139.93 39.65 1.98 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.579 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.487 ' O ' ' CA ' ' A' ' 2' ' ' GLY . 28.9 mm -124.83 117.83 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.691 0.281 . . . . 0.0 110.48 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.466 ' HA2' ' HB3' ' A' ' 4' ' ' PHE . . . -118.64 -175.09 16.33 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.973 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.97 102.69 5.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.76 0.315 . . . . 0.0 110.727 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.86 116.85 29.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.027 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t 53.83 30.23 11.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.972 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 93.22 -15.61 62.52 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.628 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.2 m -86.58 146.55 26.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.804 0.335 . . . . 0.0 110.819 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.8 HD23 ' HB2' ' A' ' 33' ' ' SER . 1.0 OUTLIER -72.97 128.24 34.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 3.2 pt -135.1 172.09 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.079 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -123.9 138.49 54.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.676 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 5.7 mp -68.13 98.64 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.851 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.31 -0.853 . . . . 0.0 111.119 179.962 . . . . . . . . 0 0 . 1 stop_ save_